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ABSTRACT 
Hemorrhagic fever viruses cause severe infections characterized by a hyperactive 
immune response that often leads to multiorgan failure and death. Current diagnostic tests 
are based on detecting viral proteins and nucleic acids in the blood. These are late-stage 
events during infection, which makes it impossible to perform a diagnosis before they are 
present in the collected sample. In this thesis, I explore an alternative approach using the 
transcriptional changes of circulating immune cells during the early stages of infection to 
identify unique markers of viral infection. The main advantage of this method is that it 
can be used to identify highly pathogenic viruses before standard detection methods 
become effective. 
 I initially used RNA sequencing data to compare the host patterns of expression 
of macaques infected with either Lassa virus or Marburg virus, two related hemorrhagic 
fever viruses. I identified a set of genes that quickly become upregulated after a viral 
infection and remain highly expressed throughout the entire disease course, irrespective 
		 v 
of the specific virus that caused the infection. I was also able to identify a set of 
biomarker genes that follow unique patterns of expression depending on the type of 
infection. I used an independent dataset to validate the potential of these genes to be used 
as biomarkers of infection. Additionally, I compared these results to the patterns of 
expression of macaques infected with Ebola virus, looking at multiple experimental 
conditions, tissues and routes of infection. Finally, I validated the host patterns of 
expression using two independently generated datasets corresponding to infection by 
different strains of arenaviruses and filoviruses.  
Studying the host immune response has the potential to improve the diagnosis of 
viral hemorrhagic fevers and other diseases. It can also accelerate our efforts to 
understand the underlying molecular mechanisms that lead to pathogenesis and severe 
disease. 
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CHAPTER 1  
INTRODUCTION 
 Two opposing forces determine the severity of disease associated with an 
infection: the ability of a pathogen to replicate and spread inside the host, and the ability 
of the host’s immune system to detect and stop the infection. Pathogenesis—the 
molecular mechanism that leads to a disease state—can vary widely depending on the 
causative agent. Some infections are asymptomatic or cause only minor disease, such as 
those caused by human rhinoviruses and adenoviruses. Other infections are associated 
with severe clinical symptoms and high fatality rates, such as those caused by 
hemorrhagic fever viruses. Even among hemorrhagic fever viruses, severity rates vary 
significantly, and can range from less than 1% to 90% case fatality rates. The reasons for 
these variations are not well understood, but it has been proposed that severe disease is 
caused by an overactive host response that is ineffective against infection and leads to 
aggravated symptoms (Günther & Lenz, 2004; Mohamadzadeh, Chen, & Schmaljohn, 
2007). 
Ebola virus, Marburg virus and Lassa virus are among the most severe pathogens 
that are thought to be associated with a dysregulated immune response. They cause 
severe febrile illnesses that often lead to bleeding disorders and death, they have no 
associated FDA-approved treatments or vaccines, and they pose a critical risk to public 
health. The effect that these viruses have on the immune response has been partially 
studied in cell culture or animal models, but the majority of studies were end-point 
examinations or they were limited to a handful of genes. In this dissertation, I follow a 
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multiple-timepoint comprehensive approach to describe the transcriptional changes that 
circulating immune cells undergo after the host becomes infected by either Lassa virus, 
Marburg virus or Ebola virus, and how these changes vary depending on the infecting 
pathogen and the stage of disease progression.  
This chapter summarizes the virology, epidemiology, and pathogenesis of these 
viruses, as well as the clinical manifestations, and host immune responses that take place 
after infection. The two filoviruses, Ebola virus and Marburg virus, are presented first, 
followed by the arenavirus, Lassa virus.  
 
1.1 Filoviruses 
Ebola virus and Marburg virus are members of the Filoviridae family.  They have 
single-stranded negative-sense RNA genomes that encode seven structural proteins 
(nucleoprotein, NP; VP35; VP40; glycoprotein, GP; VP30; VP24; and RNA-dependent 
RNA polymerase, L) as well as two nonstructural proteins (soluble glycoprotein, sGP; 
and small soluble glycoprotein, ssGP). Eight different filoviruses have been identified 
(Kuhn et al., 2012): five in the Ebolavirus genus (Ebola virus, EBOV; Sudan virus, 
SUDV; Taï Forest virus, TAFV; Bundibugyo virus, BDBV; and Reston virus, RESTV), 
two in the Marburgvirus genus (Marburg virus, MARV; and Ravn virus, RAVV), and 
one in the recently discovered Cuevavirus genus (Lloviu virus, LLOV).  
Before 2014, Ebola virus outbreaks have been documented in Gabon, Congo, and 
the DRC (Figure 1.1A). The largest outbreaks of this virus species were Yambuku (1976, 
318 cases, 88% case fatality rate) and Kikwit (1995, 315 cases, 79% case fatality rate), 
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both in the DRC. Sudan virus outbreaks have only occurred in South Sudan (Nzara, 1976, 
284 cases, 53% CFR) and Uganda (Gulu, 2000, 425 cases, 53% CFR). Bundibugyo virus 
outbreaks have taken place in the border between Uganda and the DRC, notably in 2007 
(149 cases, 25% CFR). As seen in Figure 1.1A, all pre-2014 Ebola cases occurred in the 
eastern equatorial region of Africa, with the exception of a single case reported in South 
Africa, as well as the only known case of Tai Forest virus case (Taï Forest National Park, 
1994), which took place in Côte d’Ivoire and was not lethal.  
After 2014, the geographical distribution of Ebola virus disease changed 
dramatically with a major epidemic that began in Guinea and spread through several 
West African countries, including Liberia and Sierra Leone, and which resulted in more 
than 27,000 cases and at least 11,000 deaths (41% CFR) (Figure 1.1B) (Centers for 
Disease Control and Prevention, 2015a). This was the largest disease outbreak ever 
recorded, and the threat of a possible spread beyond West Africa has highlighted the 
importance of studies that focus on understanding the pathogenesis and the development 
of potential treatment and prevention strategies. 
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Figure 1.1. Distribution map of Ebola virus disease in Africa, before and after 2014.  
Circles represent individual outbreaks. Circle radius is proportional to the number of 
reported cases. Circle color represents different Ebolavirus genera. (A) Ebola virus 
outbreaks before 2014 took place in Gabon, Congo, and the former Zaire (now DRC). 
Sudan virus outbreaks have only taken place in South Sudan and Uganda. Bundibugyo 
virus outbreaks have taken place in the border between Uganda and the DRC. The only 
reported case of Tai Forest virus took place in the Taï Forest National Park in the Ivory 
Coast. (B) In 2014, a large Ebola virus epidemic spread throughout the West African 
countries of Guinea, Liberia and Sierra Leone.  
 
Similar to the pre-2014 pattern of Ebola disease, the majority of Marburg 
outbreaks have taken place in equatorial Africa. The two largest were reported in the 
DRC (Durba, 1998, 154 cases, 83% case fatality rate) and in Angola (Uige province, 
2004, 252 cases, 90% case fatality rate) (Figure 1.2) (Centers for Disease Control and 
Prevention, 2015b). No Marburg outbreaks have yet been reported in Western Africa, but 
species distribution frameworks used to model the potential geographic spread of 
Marburg virus into this region have concluded that this is a realistic scenario (Pigott et 
al., 2015). 
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Figure 1.2. Distribution map of Marburg virus disease.  
The majority of Marburg outbreaks have taken place in equatorial Africa. Circles 
represent individual outbreaks. Circle radius is proportional to the number of reported 
cases. 
 
Bats are believed to be the reservoir species for Ebola virus. Three species of 
African fruit bats (Hypsignathus monstrosus, Epomops franqueti, and Myonycteris 
torquata) were found to harbor Ebola viral RNA and anti-Ebola antibodies (Eric M Leroy 
et al., 2005), but isolating live virus from these animals proved unsuccessful. In contrast, 
ecological investigations in 2007 led to the identification of Egyptian fruit bats (Rousettus 
aegyptiacus) as the likely reservoir species for Marburg virus. This was reported after 
successfully isolating live virus from bats captured in a Ugandan cave where miners had 
contracted the disease (Towner et al., 2009).  
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1.2 Clinical manifestations of Ebola Virus Disease and Marburg Virus 
Disease 
The clinical manifestations and pathogeneses of Ebola Virus Disease (EVD) and 
Marburg Virus Disease (MVD) are very similar. Infection is thought to occur through 
close contact with body fluids from infected animals or humans (Rougeron, Feldmann, 
Grard, Becker, & Leroy, 2015). The mean incubation period—the time between infection 
and the onset of symptoms—ranges between 2 and 21 days, but is typically closer to 5-10 
days. Patients become ill abruptly, with common symptoms including fever, vomiting, 
diarrhea, and headache (Brauburger, Hume, Mühlberger, & Olejnik, 2012; Feldmann & 
Geisbert, 2011; Kortepeter, Bausch, & Bray, 2011; Siddhartha Mahanty & Bray, 2004; 
WHO Ebola Response Team, 2014). Hemorrhagic symptoms vary in severity and are 
present on one third of patients during the peak of the illness; they include petechiae, a 
maculopapular rash, ecchymoses and mucosal bleeding (Bwaka et al., 1999; Feldmann & 
Geisbert, 2011; Rougeron et al., 2015). Laboratory markers of advanced infection include 
a marked fall in blood lymphocyte and platelet count, and a rise in neutrophils and serum 
aminotransferase concentrations (Bradfute et al., 2010; Bwaka et al., 1999; Feldmann & 
Geisbert, 2011; Wauquier, Becquart, Padilla, Baize, & Leroy, 2010). During the late 
stage of infection, patients with fatal disease experience neurological symptoms 
(confusion, delirium, seizures), multi-organ failure (pancreas, liver, kidney), hypovolemic 
shock and diffuse intravascular coagulopathy (Feldmann et al., 2007; C J Peters & 
LeDuc, 1999). Patients that survive the disease improve around days 7-11 after symptom 
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onset, as the humoral response develops and the virus is cleared from the blood (Ksiazek 
et al., 1999; Rougeron et al., 2015). 
 
1.3 Filovirus pathogenesis 
The exact mechanism of filovirus pathogenesis is unknown, but there is 
significant information about how these viruses infect cells. Ebola virus and Marburg 
virus enter the body through lymphatic or blood vessels and initially target monocytes, 
macrophages, and dendritic cells (Alves et al., 2010; Thomas W Geisbert, Hensley, et al., 
2003; Schnittler & Feldmann, 1998; Ströher et al., 2001). It is thought that these infected 
cells release large quantities of proinflammatory cytokines and chemokines, like TNF-
alpha and IL1-beta, which leads to the recruitment of additional macrophages to the 
infected area and is thought to result in vascular leakage (Bosio et al., 2003). It also 
causes neutrophils to invade nearby tissue and cause lesions (Gerszten et al., 1999). 
Furthermore, macrophages start overexpressing tissue factor, which contributes to the 
diffuse intravascular coagulopathy that is characteristic of late-stage filovirus infection (S 
Baize et al., 1999; Schnittler & Feldmann, 1998; Wauquier et al., 2010). An additional 
mechanism contributing to pathogenesis is a significant decrease in the number of 
lymphocytes, especially T cells and NK cells (Thomas W Geisbert, Hensley, et al., 2003). 
These cells are not permissive to filovirus infection, but they undergo massive bystander 
apoptosis through a mechanism that is not entirely understood (T W Geisbert et al., 2000; 
Hensley, Alves, et al., 2011; Wauquier et al., 2010). It is thought that these two 
processes—increased levels of circulating proinflammatory cytokines and lymphocyte 
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apoptosis—are caused by a dysregulated immune response, which explains the inability 
of fatal patients to control viral replication (S. Baize, Leroy, Mavoungou, & Fisher-Hoch, 
2000; S Baize et al., 1999; Feldmann & Geisbert, 2011; Thomas W Geisbert, Hensley, et 
al., 2003; Misasi & Sullivan, 2014).  
 
1.4 Host immune response to filovirus infection 
 Nonfatal filovirus infections are associated with an antibody response directed 
against NP and VP40, cell-mediated responses to GP, and virus clearance driven by the 
cytotoxic T-cell response (Paessler & Walker, 2013). In contrast, fatal filovirus infections 
are characterized by a dysregulated innate immune response and an ineffective adaptive 
immune response. In vitro and in vivo studies have shown that filovirus-infected dendritic 
cells and macrophages produce chemokines, such as CCL3 (MIP-1) and CCL2 (MCP-1), 
that lead to the recruitment of additional macrophages (Thomas W Geisbert, Hensley, et 
al., 2003; Gupta, Mahanty, Ahmed, & Rollin, 2001; Hensley, Alves, et al., 2011; 
Wauquier et al., 2010). Additionally, these cells also secrete inflammatory mediators, 
such as TNF-alpha, CXCL8, CXCL10, IL2, and IL6 and IL10, in much higher 
concentrations in fatal than in nonfatal cases (S Baize et al., 1999, 2002; Thomas W 
Geisbert, Hensley, et al., 2003; Hensley, Young, Jahrling, & Geisbert, 2002; Villinger et 
al., 1999; Wauquier et al., 2010). T cell-priming by dendritic cells is likely impaired by 
this uncontrolled release of cytokines and, together with the associated massive bystander 
lymphocyte apoptosis, is thought to contribute to the lack of an effective adaptive 
immune response during filovirus infection (Bradfute & Bavari, 2011). 
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A central player in the innate immune response is the family of cytokines known 
as Type I interferons. Filoviruses have evolved powerful mechanisms to inhibit their 
production, as well as to prevent the activation of the interferon signaling pathways. Once 
secreted, interferon binds to the receptors in neighboring cells (as paracrine signaling), or 
to those in the same cell (as autocrine signaling) (Christopher F. Basler, 2015), and 
initiate the JAK-STAT signaling cascade, which results in the upregulation of hundreds 
of genes (known as interferon-stimulated genes, or ISGs). The proteins that these genes 
encode collectively improve the cell’s ability to inhibit virus replication. Interferon 
expression is induced by the activation of pattern recognition receptors, like RIG-I 
(DDX58) or MDA5 (IFIH1). These receptors become activated after sensing RNA 
products of virus replication, such as 5´ triphosphates and dsRNAs (Kawai & Akira, 
2010). A fact that highlights the importance of the interferon pathway is that in wild-type 
mice, Ebola virus infection doesn’t result in disease. However, knockout mice lacking the 
type I interferon receptor (IFNAR), or the main interferon signaling protein (STAT1), are 
uniformly susceptible to fatal Ebola infection (Bray, 2001). Ebola virus protein VP35 and 
VP24, as well as Marburg VP40, are reported to be the main inhibitors of interferon 
production and signaling. As represented in Figure 1.3A, Ebola VP35 prevents the 
phosphorylation of IRF3 and IRF7, which are transcription factors that dimerize after 
becoming phosphorylated, translocate to the nucleus and initiate the synthesis of 
interferon (C. Basler & Mikulasova, 2003; Cárdenas et al., 2006; T. H. Chang et al., 
2009; Hartman, Towner, & Nichol, 2004; Prins, Cárdenas, & Basler, 2009). Additionally, 
as seen in Figure 1.3B, Ebola VP24 prevents phosphorylated STAT1 from translocating 
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to the nucleus and inducing the production of ISGs (Reid et al., 2006), while Marburg 
VP40 prevents the phosphorylation of the interferon receptor-associated kinases JAK1, 
TYK2, STAT1 and STAT2 (Valmas et al., 2010).  
 
 
Figure 1.3: Filovirus inhibition of IFN signaling. 
(A) Type I interferons are regulated by the transcriptional factors IRF3 and IRF7. When 
these factors become phosphorylated, they are able to dimerize and translocate to the 
nucleus to bind the promoter sequence of type I interferon genes (IFNB, in this case). 
Ebola VP35 inhibits the phosphorylation event that makes this possible. (B) When type I 
interferons bind the interferon receptor (IFNAR), they cause the phosphorylation of 
STAT1 and STAT2, which are then able to form a heterodimer along with the IRF9 
transcription factor, translocate to the nucleus, and bind the promoter regions (Interferon-
Stimulated Response Elements) that control the transcription of ISGs. Marburg VP40 
blocks the phosphorylation event, and Ebola VP24 prevents phosphorylated STAT1 from 
translocating into the nucleus. 
 
Numerous studies have investigated how filovirus infection affects interferon 
production, with contrasting results (summarized in  
Table 1.1). Some in vitro studies report that filoviruses completely limit or block 
interferon production (Bosio et al., 2003; Gupta et al., 2001; Harcourt, Sanchez, & 
Margaret, 1999; Kash, Mühlberger, & Carter, 2006), while others report that it increases 
(Thomas W Geisbert, Young, Jahrling, Davis, Larsen, et al., 2003; Hensley et al., 2002). 
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Similarly, several in vivo studies report that filovirus infection is associated with 
increasing concentrations of interferon in humans, macaques and mice (Thomas W 
Geisbert, Hensley, et al., 2003; Gupta et al., 2001; Hensley et al., 2002; Siddhartha 
Mahanty, Gupta, et al., 2003; Villinger et al., 1999; Warfield et al., 2009), while one 
study reports that such increases were not observed (Wauquier et al., 2010).  
Experiment 
type Virus 
Infected host or 
cell type 
Production 
of Type I 
interferon 
Reference 
In vitro EBOV (check) 
Endothelial cells 
(HUVEC) NO Harcourt1999 
In vitro EBOV Macrophages (human) NO Gupta2001 
In vitro 
EBOV 
and 
MARV 
Dendritic cells 
(human) NO Bosio2003 
In vitro EBOV Macrophages and dendritic cells YES Hensley2002 
In vitro EBOV Endothelial cells (HUVEC) YES Geisbert2003a 
In vitro 
Mouse-
adapted 
RAVV 
BALB/c mice YES (only 3 dpi) Warfield2009 
In vivo EBOV Human YES Villinger1999 
In vivo EBOV Human YES (serum) Gupta2001 
In vivo EBOV Cynomolgus and rhesus macaques 
YES (by 5 
dpi, serum) Hensley2002 
In vivo EBOV 
Mice (BALB/c, 
subcutaneous 
injection) 
YES (by 2 
dpi, in liver 
spleen and 
serum) 
Mahanty2003a 
In vivo EBOV Cynomolgus macaques 
YES (by 5-6 
dpi, serum) Geisbert2003c 
In vivo MARV (Ci67 
Cynomolgus 
macaque (plasma, 
YES (by 6 dpi 
in plasma, 3 Fritz2008 
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strain) spleen) dpi in spleen) 
In vivo EBOV Human NO Wauquier2010 
 
Table 1.1 In vitro and in vivo studies that investigated the presence of interferon 
after filovirus infection.  
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These inconsistent results likely have multiple explanations. One may be cell 
variability: in vitro studies typically derive interferon-producing cells (macrophages and 
dendritic cells) from monocytes, but these cells may not accurately reproduce the in vivo 
infection scenario; for example, by not producing interferon at natural levels, or doing so 
intermittently. Another explanation could be that different studies measured different 
interferon isoforms, and this may lead to different rates of ISG activation. These 
contradictory findings suggest that a more comprehensive effort to understand the 
interferon response is necessary.  
To this end, in Chapter 3, I investigate the transcriptional patterns of circulating 
immune cells in a macaque model of Ebola infection. My results show that approximately 
50 interferon-stimulated genes show strong increases in expression early after infection, 
which supports the view that the innate immune response becomes activated during 
filovirus infection. I also compared two different routes of infection (aerosol and 
intramuscular) and saw similar patterns of expression. The aerosol model also showed 
that these innate immune responses take place in primary and secondary target tissues. 
Lastly, I contrasted these patterns of expression to those of Ebola-vaccinated macaques 
and found that this treatment rendered the innate immune response almost non-existent. 
This runs counter to the prevailing hypothesis that innate immune signaling is suppressed 
during infection. 
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1.5 Arenaviruses 
The geographic region where the 2015 Ebola outbreak took place is also the 
location where most cases of Lassa fever take place every year. Lassa virus is a member 
of the Arenaviridae family. It has a single-stranded RNA genome composed of two 
segments. Each RNA segment is ambisense, encoding one gene in the positive sense, and 
another in the negative sense. The large segment encodes the RNA-dependent RNA 
polymerase (L), and a zinc-binding protein (Z). The small segment encodes the structural 
proteins nucleoprotein (NP), and the glycoprotein precursor (GPC); which is later cleaved 
into the envelope proteins (G1 and G2). Arenaviruses are classified into New World and 
Old World arenaviruses. New World arenaviruses include viruses common in the 
Americas, and Old World arenaviruses are found in Africa. The exception is 
Lymphocytic Choriomeningitis Virus (LCMV), which has a worldwide distribution but is 
classified as an Old World arenavirus. Hemorrhagic fever viruses in the New World 
arenaviruses include Junin virus (JUNV), Machupo virus (MACV), Guanarito virus 
(GTOV), Chapare virus (CHPV), and Sabia virus (SABV). The only two Old World 
arenaviruses that are known to cause hemorrhagic fevers are Lujo virus (LUJV) and 
Lassa virus (LASV). 
Lassa virus is the causative agent of Lassa fever, a major endemic disease in West 
Africa, mainly in Guinea, Sierra Leone, Liberia and Nigeria (Figure 1.4). Based on the 
high rates of Lassa virus seroconversion among Sierra Leonean villagers (5%-20% per 
year), it was estimated that the virus infects 100,000-300,000 people every year with a 
case fatality rate of 1%-2% (J. McCormick & Webb, 1987). This rate has been shown to 
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be much higher among hospital-admitted patients (up to 69%) (S P Fisher-Hoch et al., 
1995; Shaffer et al., 2014). The true rate of Lassa Fever infections in West Africa is 
likely obscured by the lack of systematic surveillance and convenient diagnostics (Juan C 
Zapata & Salvato, 2015). 
 
Figure 1.4. Distribution map of Lassa Fever.  
Guinea, Sierra Leone, Liberia and Nigeria are associated with large recurring epidemics 
(dark blue). Areas in light blue report sporadic infections. Elsewhere, the frequency of 
Lassa fever is unknown (gray). 
 
The reservoir species of Lassa virus is the African rodent Mastomys natalensis 
(Lecompte et al., 2006; Monath, Newhouse, Kemp, Setzer, & Cacciapuoti, 1974), which 
is ubiquitous throughout sub-Saharan Africa. These rodents live in close proximity to 
humans. In some provinces in Sierra Leone, up to 90% of rodents caught in houses are 
Mastomys; a large proportion of which carry Lassa virus (Günther & Lenz, 2004). 
Humans likely become infected by breathing air or consuming food that is contaminated 
with Mastomys urine or other excreta (Monath et al., 1974).  
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1.6 Clinical manifestations of Lassa Fever 
Lassa fever has a longer incubation period than Ebola virus and Marburg virus, 
and it ranges from 7 to 18 days. Initial symptoms are nonspecific and similar to those of 
flu. They include fever, weakness, malaise, severe headache, and a sore throat (J. 
McCormick & Webb, 1987). This lack of distinctive initial symptoms makes the early 
diagnosis difficult and delays the initiation of treatment (Juan C Zapata & Salvato, 2015). 
Around 50% of patients also experience nausea and diarrhea. There is no characteristic 
skin rash and, in contrast with filovirus infection, no coagulation disorders (S P Fisher-
Hoch et al., 1985). The liver is the most consistently affected organ in humans, and fatal 
disease is correlated with increases in the concentration of aspartate transaminase (AST) 
and alanine transaminase (ALT) in serum (Günther & Lenz, 2004). Bleeding is only seen 
in 15% to 20% of patients and is mainly limited to mucosal surfaces. In contrast to other 
hemorrhagic fevers, diffuse intravascular coagulation is rarely seen in patients with Lassa 
fever (Cummins et al., 1989; Susan P. Fisher-Hoch, McCormick, Sasso, & Craven, 
1988). 
 
1.7 Lassa virus pathogenesis 
The primary routes of virus entry are thought to be cuts or abrasions on the skin, 
as well as close contact with secretions or blood from infected patients (J. B. McCormick 
& Fisher-Hoch, 2002). Macrophages and dendritic cells become infected at the site of 
viral entry at an early stage and facilitate the dissemination of the virus via blood and 
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lymph, infecting all the major organs (Walker et al., 1982). Infected macrophages have 
two detrimental effects: they lead to the formation of blood clots due to overexpressed 
tissue factor (Thomas W Geisbert, Young, Jahrling, Davis, Kagan, et al., 2003), and they 
increase vascular leakage due to the uncontrolled release of the inflammatory proteins 
(Zampieri, Sullivan, & Nabel, 2007).  
The broad tropism of the Lassa virus is explained by the ubiquity of its cellular 
receptors (alpha-dystroglycan (Cao et al., 1998; Kunz et al., 2005) and high-mannose 
receptors (Shimojima, Stroher, Ebihara, Feldmann, & Kawaoka, 2012)). Similar to 
filovirus infection, there is strong bystander apoptotic lymphopenia and neutrophilia (J. 
B. McCormick & Fisher-Hoch, 2002). The late stage of disease is characterized by an 
uncontrolled rise in virus load in multiple organs.  
In survivors, deafness is one of the most common symptoms during the 
convalescent stage; 30% of hospitalized patients suffer acute loss of hearing in one or 
both ears (Cummins, 1990). It remains unknown if this damage is a side-effect of viral 
replication or of the immune response.  
 
1.8 Host immune response to Lassa virus infection 
Fatal Lassa fever cases are associated with a dysregulated host innate immune 
response that is unable to stop viral replication (Johnson et al., 1987; Clarence J Peters & 
Zaki, 2002). This is believed to take place because dendritic cells, which are primary 
targets of Lassa virus, become infected and are only able to produce a limited panel of 
cytokines, their maturation becomes impaired and they are less capable of activating T 
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cells (Bosio et al., 2003; Lubaki et al., 2013; Siddhartha Mahanty, Hutchinson, et al., 
2003; B. Yen, Mulder, Martinez, & Basler, 2014).  Additional human studies about the 
concentrations of cytokines during infection have revealed that low serum levels of the 
pro-inflammatory chemokines CXCL8 (IL8) and CXCL10 (IP-10) and high levels of the 
anti-inflammatory cytokine IL6 are strongly correlated with fatal outcome (S Mahanty et 
al., 2001). In macaques, high levels of type I interferon can be found in the blood of both 
fatal and nonfatal cases, but while the concentration of interferon decreases quickly in 
nonfatal cases, it remains high in fatal cases (Sylvain Baize et al., 2009). This high level 
of interferon is probably unable to mitigate the massive viral replication observed at the 
terminal stages of disease, and likely contributes to pathogenesis. 
 Neutralizing antibodies to Lassa GP appear in survivors months after the infection 
has been resolved (Peter B. Jahrling, Frame, Rhoderick, & Monson, 1985), and it is 
believed that cell-mediated immunity plays a more important role in Lassa virus 
clearance than humoral immunity. In macaques, nonfatal cases have high numbers of 
activated T cells while fatal cases are associated with lower levels of T cell activation and 
uncontrolled viral replication (Sylvain Baize et al., 2009; Yun & Walker, 2012). In 
humans, strong memory CD4+ T cell responses against LASV NP and GP have been 
detected in LASV-seropositive individuals living in West Africa, where Lassa is 
endemic. This suggests that nonfatal infections are associated with the activation of CD4 
T cells (J ter Meulen et al., 2000; Jan Ter Meulen et al., 2004). The failure of the innate 
immune system to activate a rapid T cell response capable of clearing the infection may 
lead these cells to contribute to further pathogenesis. 
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 In summary, hemorrhagic fever virus infections are associated with a complex 
pathogenesis and an immune response that remains only partially understood. The study 
of individual components of these complex processes can provide useful information, but 
the main limitations are the number of genes that can be studied simultaneously, or the 
frequency with which they can be measured throughout infection. Transcriptional 
profiling is a high-throughput method that makes it possible to accurately quantify the 
amount of expression of every gene at multiple times post-infection and provides an 
unbiased view of the gene expression patterns that take place in a given sample. 
 
1.9 Transcriptional profiling 
Identifying the transcriptional patterns of host genes during infection has made it 
possible to increase our understanding of pathogenesis, help us distinguish between 
severe and asymptomatic patients, and differentiate between bacterial and viral infections  
(Barrenas et al., 2015; Huang et al., 2011; Kash et al., 2006;  a. K. Zaas et al., 2013; Juan 
C Zapata & Salvato, 2015). The first studies that measured host gene expression changes 
after a hemorrhagic fever virus infection used northern blot or RT-PCR assays, which 
limited the number of observations to a handful of genes (S Baize et al., 1999; C F Basler 
et al., 2000; Harcourt et al., 1999; E M Leroy, Baize, Debre, Lansoud-Soukate, & 
Mavoungou, 2001; E. Leroy, Baize, & Volchkov, 2000; Ströher et al., 2001). With the 
arrival of microarrays and high-throughput sequencing technology, the number of genes 
that could be observed in a single experiment increased dramatically.  
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Several studies have applied this approach to understanding the host patterns of 
transcription during hemorrhagic fever virus infection. One study looked at the gene 
expression changes of liver cells and found that immune response genes become 
upregulated after Ebola infection, but that the expression of interferon-stimulated genes 
does not change after infection, presumably due to viral inhibition of the interferon 
response (Kash et al., 2006). This was confirmed by another study that showed that liver 
cells infected with a VP35-mutated Ebola virus strain resulted in a strong upregulation of 
ISGs (Hartman, Ling, Nichol, & Hibberd, 2008). Additional studies looked at the patterns 
of Ebola infection during live infection in macaques (Rubins et al., 2007) and mice 
(Cilloniz et al., 2011), and identified strong increases in the expression of cytokine, 
chemokines and apoptotic genes, which can help explain the clinical symptoms observed 
throughout infection. These studies illustrate the usefulness of applying a whole-
transcriptome approach to understand the activation of host responses, since it makes it 
easy to identify which genes may be playing a critical role throughout infection and can 
help guide the development of new drugs aimed at modulating this response. 
In Chapter 2, I use transcriptional sequencing data to characterize the immune 
responses of macaques infected with different hemorrhagic fever viruses, Lassa virus 
(Malhotra et al., 2013) and Marburg virus (Connor et al., 2015, in press). I describe the 
changes in gene expression that make up the common immune response in both types of 
infection and I discuss their function. Additionally, I identify a subset of genes whose 
differences in expression during the early stages of infection are strong enough to 
distinguish Lassa infection from Marburg infection. I also explain how these results were 
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validated using two methods: by recapitulating the expression levels of a subset of genes 
using RT-PCR, and by applying multidimensional scaling on the microarray expression 
values of a partially independent set of samples. These results serve as evidence that host 
transcriptional signatures have the potential to differentiate between specific viral 
infections during the early stages of disease. 
In Chapter 3, I apply RNA sequencing to determine the major transcriptional 
changes that take place during Ebola virus infection in a macaque model of infection. I 
compare the strong response of interferon-stimulated genes, which is constant across all 
tissues, with the gene expression changes of genes that take place only in specific tissues. 
I also contrast the serum concentrations of a number of cytokines reported by two Ebola 
pathogenesis studies and correlate them with the expression levels that we observe in 
samples from liver, spleen and peripheral blood mononuclear cells. 
In Chapter 4, I use gene expression data from a recent study that looked at the 
host response of macaques to different arenaviruses (Rasmussen et al., 2014), and 
compare it to the patterns of expression of Lassa-infected macaques described in 
Chapter 2. I show that the expression patterns I found to be important in distinguishing 
Lassa and Marburg infection are also seen in an independent dataset, which serves as an 
indicator that the signal we identified can be reliably detected under different 
experimental conditions. Additionally, I compare the patterns of gene expression from 
Chapter 3, to those obtained in an independent study that infected macaques with Ebola 
and quantified the mRNA expression using microarrays (Rubins et al., 2007). 
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1.10 Complementary side projects 
In addition to my main research project, I have taken part in a number of side 
projects that benefited from applying a bioinformatics approach. Here, I will describe two 
of the most substantial research questions that I have worked on: 
1) the study of host expression patterns during vaccinia virus infection, and  
2) the metagenomic analysis of the viral biodiversity of rodents in French Guiana. 
1.10.1 Expression of host factors during vaccinia virus infection.  
Vaccinia virus is a DNA virus that requires the presence of host proteins to 
complete its life cycle. The aim of this project was to identify host genes that increased in 
expression during vaccinia infection and to understand their role in facilitating vaccinia 
replication. I was able to identify a number of differentially regulated genes and found 
that a majority of them were being targeted by a common transcription factor, the heat-
shock master transcriptional regulator HSF1. This project is described in Chapter 5. 
1.10.2 Viral biodiversity of rodent communities in French Guiana.  
Metagenomics makes it possible to collect biological samples from an 
environment and determine the composition of the microbial communities they contain. 
The goal of this project was to identify the viruses that were present in different tissue 
samples from rodent and bat species in French Guiana. I was able to characterize a 
number of previously unreported viral species, including a high coverage sequence of a 
novel strain of arenavirus (Lymphocytic choriomeningitis virus). This project is 
described in Chapter 6. 
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CHAPTER 2  
LASSA AND MARBURG VIRUSES ELICIT DISTINCT HOST 
TRANSCRIPTIONAL RESPONSES EARLY AFTER INFECTION 
 
2.1 Preamble 
Lassa virus and Marburg virus are two causative agents of viral hemorrhagic 
fever. Their diagnosis is difficult because patients infected with either pathogen present 
similar nonspecific symptoms early after infection. Current diagnostic tests are based on 
detecting viral proteins or nucleic acids in the blood, but these cannot be found during the 
early stages of disease, before the virus starts replicating in the blood. Using the 
transcriptional response of the host during infection can lead to earlier diagnoses 
compared to those of traditional methods. In this study, we use RNA sequencing to obtain 
a high-resolution view of the in vivo transcriptional dynamics of peripheral blood 
mononuclear cells (PBMCs) throughout both types of infection. We report a subset of 
host mRNAs, including heat-shock proteins like HSPA1B, immunoglobulins like IGJ, 
and cell adhesion molecules like SIGLEC1, whose differences in expression are strong 
enough to distinguish Lassa infection from Marburg infection in non-human primates. 
We have validated these infection-specific expression differences by using microarrays 
on a larger set of samples, and by quantifying the expression of individual genes using 
RT-PCR. These results suggest that host transcriptional signatures are correlated with 
specific viral infections, and that they can be used to identify highly pathogenic viruses 
during the early stages of disease, before standard detection methods become effective. 
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The viral infections and the RNA isolation were performed at the United States 
Army Medical Research Institute of Infectious Diseases (USAMRIID). These samples 
were sent to Boston University, where they were prepared for sequencing, and they were 
sequenced at Tufts University. I analyzed the results of the RNA sequencing samples, as 
well as the microarray samples that were used for validation. I also performed the RT-
PCR validation of HSPA1B and SIGLEC1. 
Note: The majority of the work presented in this chapter has been previously 
published in (Caballero et al., 2014). 
 
2.2 Introduction 
 Lassa fever and Marburg fever are acute viral hemorrhagic illnesses. Lassa Fever 
is caused by the Lassa virus and it is endemic to a large region of West Africa, where 
100,000-300,000 cases have been estimated to occur each year (J. B. McCormick et al., 
1987). More than 20 cases have been imported to the United States, Canada, United 
Kingdom and Japan since 1969, when the disease was first recognized (Buckley & 
Casals, 1970; Macher & Wolfe, 2006). The case fatality rate in hospitalized patients has 
recently been reported to be 69% (Shaffer et al., 2014). Marburg fever is a viral 
hemorrhagic illness caused by the Marburg virus. Several outbreaks have been reported 
in the Democratic Republic of the Congo (Daniel G Bausch et al., 2006) and Angola 
(Towner et al., 2006) with case fatality rates approaching 90%. Travelers visiting Uganda 
have also imported the virus into the Netherlands (Timen, 2009). Both diseases lack 
effective therapeutics and early diagnostics. 
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 Early clinical symptoms of infection are shared between different hemorrhagic 
fevers, and they resemble those of a flu-like illness: fever, headache, myalgia, sore throat, 
vomiting, diarrhea and dry cough (Drosten, Kümmerer, Schmitz, & Günther, 2003). 
During the 2014 West Africa Ebola outbreak, samples from suspected patients were 
routinely tested to rule out infection by Lassa virus, since both pathogens were present in 
the region and distinguishing between them was an important part of the differential 
diagnosis (Sylvain Baize et al., 2014; Green, 2014). 
 Current diagnostic tests for Lassa and Marburg fevers include enzyme-linked 
immunosorbent assays (ELISA) and reverse transcriptase polymerase chain reaction (RT-
PCR) (D G Bausch et al., 2000; Grolla, Lucht, Dick, Strong, & Feldmann, 2005; Panning 
et al., 2010). Because these methods rely on the direct detection of viral proteins or 
nucleic acids in the blood, they are not useful during the incubation period of the virus, 
which happens during the early stages of infection (D G Bausch et al., 2000; Drosten et 
al., 2003). Additionally, most potential therapies for these pathogens—ribavirin for Lassa 
virus (P B Jahrling, Peters, & Stephen, 1984), post-infection vaccination for filoviruses 
(Thomas W Geisbert & Feldmann, 2011), and stable nucleic acid-lipid particle (SNALP) 
treatment for Marburg virus (Ursic-Bedoya et al., 2014)—work best when administered 
early. Developing tests that diagnose these infections during the early stages of disease 
would positively impact survival. 
 One approach for developing more rapid diagnostics involves incorporating the 
host response to infection as part of the diagnostic assay. During an infection, circulating 
immune cells are present in high numbers and they respond to distress signals from many 
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different tissues by altering the levels of expression of specific genes. These changes in 
expression often take place before the virus starts replicating in the blood (viremia) (Baas 
et al., 2006; Malhotra et al., 2013), which means that they could be used to perform 
earlier diagnoses than those allowed by traditional methods. To ensure that the predictive 
power of these changes in expression can distinguish between different causative agents, 
the host gene expression profiles associated with each type of infection must be 
determined in advance. Two recent reports have used a host response signature to 
discriminate symptomatic patients with viral infections from those infected with bacteria 
(Hu, Yu, Crosby, & Storch, 2013;  a. K. Zaas et al., 2013). 
I analyzed the transcriptome of PBMCs from non-human primates (cynomolgus 
macaques) exposed to Lassa virus and to Marburg virus (Malhotra et al., 2013), and 
found that the circulating immune cells develop a robust antiviral response days before 
clinical symptoms. In this article, I show that the expression differences in the genes that 
make up this response can be used to distinguish between Lassa and Marburg infections 
as early as 3 days after exposure. 
 
2.3 Methods  
2.3.1 LASV sequential sampling study 
 The samples used in this study came from a larger sequential sampling study 
designed to characterize the disease progression of viral hemorrhagic fevers after aerosol 
exposure. Seven adult male and female cynomolgus macaques (Macaca fascicularis), 
ranging in weight from 5.5 to 8.7 kg were obtained from licensed and approved vendors. 
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During the acclimation to the biosafety level 4 (BSL4) containment suite, a pre-challenge 
blood sample (8 days before exposure) was collected to provide a baseline for further 
analyses. (These samples are referred to in this manuscript as pre-infection or 0 days 
post-infection samples.) On day 0, NHPs were anesthetized and minute volumes 
calculated by performing whole-body plethysmography (Buxco Research Systems, 
Wilmington, NC) just prior to the exposure. NHPs were exposed individually at a target 
dose of 1000 Plaque Forming Unit (PFU) of LASV Josiah in a head-only chamber in a 
class III biological safety cabinet maintained under negative pressure within a BSL-4 
laboratory. Aerosols were created by a 3-jet Collison nebulizer (BGI Inc., Waltham, MA) 
and controlled by the USAMRIID Automated Bioaerosol Exposure System (ABES-II). 
The virus preparation used to infect NHPs was free of contamination of endotoxin and 
mycoplasma. After challenge, blood samples were collected at various days post-
infection (dpi), based on approved collection allowances, as well as at euthanasia. Groups 
of two to three NHP were euthanized at 3, 6, 8 and 10 dpi, and peripheral blood 
mononuclear cells (PBMCs) were prepared from collected blood. 
2.3.2 MARV sequential sampling study 
 The Marburg study was performed under the same conditions as the Lassa study, 
with three differences: 1) The virus strain used was MARV Angola, 2) the number of 
adult male and female macaques was nine, and 3) macaques were euthanized and PBMCs 
collected from blood at 1, 3, 5, 7 and 9 dpi. 
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2.3.3 RNA processing  
 PBMCs were isolated from blood pre-diluted with saline using ACCUSPIN 
System-Histopaque-1077 tubes as per manufacturer’s recommendations, and 
subsequently lysed in TRI Reagent LS (Sigma-Aldrich, St. Louis, MO) at USAMRIID.  
2.3.4 Sequencing library preparation 
 A subset of the total RNA samples from both datasets was processed for RNA 
sequencing (Figure	2.1A). Sequencing libraries were prepared for mRNA sequencing 
using TruSeq v2 RNA Sample Preparation kits (Illumina, San Diego, CA). Briefly, per 
the manufacturer protocol, mRNA was purified from approximately 500ng to 1µg of total 
RNA per sample using poly-T oligo-attached magnetic beads, then fragmented and 
primed with random hexamers for cDNA synthesis. Multiple indexing adapters were 
ligated to the ends of the double-stranded cDNA, and the DNA fragments with adapter 
molecules on both ends were then selectively PCR enriched to create the sequencing 
libraries. Libraries were validated for size and purity on an Agilent 2100 Bioanalyzer 
using the DNA-1000 chip (Agilent Technologies, Santa Clara, CA) before they were 
normalized and pooled for multiplex sequencing. Cluster generation and sequencing were 
performed by the Analytical Core Facility at Tufts University (Department of 
Physiology).  
2.3.5 RNA sequencing analysis 
 After sequencing the Macaca fascicularis PBMC RNA samples from both types 
of infection (Lassa and Marburg), the generated reads were trimmed and the adapters 
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were removed using Trimmomatic (Bolger, Lohse, & Usadel, 2014). The processed reads 
were aligned to the Macaca mulatta genome (Ensembl release 75) using TopHat 2.0.6 
(Trapnell, Pachter, & Salzberg, 2009) with default parameters (segment length of 25, 
allowing up to 2 segment mismatches) and using the RhesusBase2 (Zhang et al., 2013) 
annotated M. mulatta transcriptome as reference. Gene counts were obtained using 
HTSeq (Anders, 2010) to count reads that aligned uniquely to each gene. Counts were 
normalized to compensate for differences in library size using the trimmed mean of M-
values normalization method (Robinson & Oshlack, 2010) included in the edgeR 
BioConductor package (Robinson, McCarthy, & Smyth, 2010). The normalized 
sequenced reads were also aligned to the Lassa virus (NCBI BioProject accession 
PRJNA14864) and Marburg virus (NCBI BioProject accession PRJNA15199) genomes 
using BWA (Li & Durbin, 2009) to quantify the number of viral reads in each sample. 
A gene was deemed to show statistically significant changes in expression at a 
specific time after infection if the moderated t-test (Robinson et al., 2010) between the 
infected and pre-infection samples resulted in a multiple testing-corrected p-value lower 
than 0.05, with an absolute fold change in expression greater or equal to 3, and an 
average number of reads across all samples greater than 4 counts per million (CPM). 
When calculating relative changes to the pre-infection samples, infected samples were 
not subtracted from their individual uninfected controls (since not every infected sample 
had a pre-infected control), but from an average of all the pre-infection samples. 
Statistical significance, however, was calculated using the individual pre-infection 
samples, not their average. 
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2.3.6 Microarray sample preparation 
 PBMCs were processed for microarray analysis as described previously (J. Y. 
Yen et al., 2011). Briefly, total RNA was extracted from the TRI Reagent LS samples, 
then amplified using the Low-Input Quick Amp Labeling kit (Agilent Technologies, 
Santa Clara, CA) and hybridized to Whole Human Genome Oligo Microarrays (Agilent 
Technologies, Santa Clara, CA) in a 2-color comparative format along with a reference 
pool of messenger RNA. Images were scanned using the Agilent High-Resolution 
Microarray Scanner and raw microarray images were processed using Agilent's Feature 
Extraction software.  
2.3.7 Microarray Expression Analysis 
 Agilent two-color human gene expression microarrays were processed using 
limma (Smyth, 2004). Expression values were obtained by calculating the log-ratio 
between the intensities of the red channel (which corresponds to experimental samples) 
and the green channel (which corresponds to Human Universal Reference RNA 
(Novoradovskaya et al., 2004)). These were later background-corrected and normalized 
using LOESS (Smyth & Speed, 2003). 
2.3.8 Multidimensional Scaling 
The limma (Smyth, 2004) implementation of Multidimensional Scaling was used 
to reduce the dimensionality of a matrix composed of the expression values of the 
following 12 genes across the 66 RNA samples: MX1, OAS1, IFI44L, CXCL10, 
HSPA1B, IGJ, HSPA1L, BIRC3, SIGLEC1, TNK2, TNFSF10, NR4A2. 
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2.3.9 Reverse Transcriptase Polymerase Chain Reaction 
RT-PCR reactions were carried out in 50 µL reactions using Power SYBR® 
Green RNA-to-CT™ 1-Step Kit from Life Technologies: 25 µL SYBR® Green RT-PCR 
Mix, 2 µL of each primer at 100 µM, and .4 µL RT Enzyme Mix. Thermal cycling was 
conducted as follows: 30 minutes at 48 ºC, 10 minutes at 95 ºC, 15 seconds at 95 ºC (40 
cycles), and 1 minute at 60 ºC (40 cycles).  
 
2.4 Results 
2.4.1 Clinical Symptoms 
Cynomolgus macaques were exposed to an aerosol dose of 1000 plaque forming 
units of Lassa virus or Marburg virus, as previously described (Malhotra et al., 2013; 
Connor et al., 2015, in press) (see Figure	2.1A). In these models, animals began to 
develop a fever around day 3 after exposure to Lassa virus and day 4 after exposure to 
Marburg virus (Figure	2.1B, Table	2.1). The onset of viremia took place around day 8 
for Lassa and day 4 for Marburg (confirmed by both plaque assay and RT-PCR). The 
liver enzymes aspartate transaminase (AST) and alanine transaminase (ALT) showed 
increased levels of concentration in both diseases around day 6. D-dimers started to 
increase around day 5 for Lassa and day 6 for Marburg. In both types of infection, all of 
these markers peaked during the late stages of infection (days 9-10). These data 
confirmed that clinical markers of infection that could be used for diagnosis (e.g. 
viremia) did not appear in these models until day 4 post-infection. 
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Figure 2.1 Quantified samples in each virus group.  
(A) Each circle represents an RNA sample isolated from the peripheral blood 
mononuclear cells (PBMCs) of a cynomolgus macaque. Grey circles represent pre-
infection samples from different macaques. Blue circles represent samples infected with 
Lassa virus. Red circles represent samples infected with Marburg virus. All samples were 
quantified using microarrays. Samples with a black border were also quantified using 
RNA sequencing. (B) Diagram of the disease timecourse highlighting the most relevant 
clinical events, from the appearance of fever 3 days post-infection to the late stage of 
disease and death. 
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 Lassa Marburg 
Fever Day 3 Day 4 
Viremia Day 8 Day 4 
Increased AST/ALT Day 6 Day 6 
Increased D-dimers Day 5 Day 6 
 
Table 2.1: Times at which clinical markers are detected in each type of infection.  
Viremia was measured using RT-PCR in the Lassa group, and RT-PCR and plaque assay 
in the Marburg group. 
 
2.4.2 RNA sequencing 
To determine the transcriptional changes that take place in the circulating immune 
system in response to a hemorrhagic fever virus infection, we quantified the abundance of 
mRNAs present in peripheral blood mononuclear cells (PBMCs) of cynomolgus 
macaques infected with either Lassa or Marburg virus. The samples were obtained before 
the animals were infected, and at multiple times after infection (see Figure	2.1A). We 
selected for polyadenylated transcripts and sequenced 12 RNA samples from each group 
using Illumina technology. This process generated an average of 46.27 ± 5.92 million 
reads per sample; 72% of which (33.46 ± 4.33 million) aligned to the M. mulatta (rhesus 
macaque) genome—the closest organism to M. fascicularis with an annotated genome. 
Multiple factors may explain why 28% of reads remained unaligned: an incomplete 
assembly of the M. mulatta genome and transcriptome, genetic differences between 
M. mulatta and M. fascicularis, or the appearance of amplification artifacts during the 
sequencing process. We assessed the expression level of individual mRNAs by counting 
the number of reads that aligned uniquely to each gene, and then normalizing this number 
to allow comparisons across all samples.  
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To determine the amount of sequencing reads that came from each virus, we 
aligned the reads to the Lassa virus and Marburg virus genomes. In the Lassa infection 
group, only the samples taken 10 days post-infection (dpi) contained viral reads (less than 
20 reads). In the Marburg infection group, around 2000 viral reads were seen 5 dpi, and 
around 80,000 reads 9 dpi. These numbers suggest that peripheral blood mononuclear 
cells are early targets for Marburg virus but not for Lassa virus. The number of viral 
reads found in PBMCs correlates well with the level of viremia, as reported in (Malhotra 
et al., 2013; Connor et al., 2015, in press). 
2.4.3 The common transcriptional response of PBMCs during Lassa and 
Marburg infection is dominated by type I interferon-stimulated genes 
To identify what transcriptional changes are shared by different hemorrhagic 
fever virus infections, we identified genes whose levels of expression 1) closely matched 
in both types of viral challenge, 2) strongly increased or decreased 3 days post-infection 
(dpi), and 3) increased or sustained this level of expression throughout the remaining time 
points (5-10 dpi). We labeled this group of genes the common response (Figure	2.2B). 
Some of its representative members include transcription factors IRF7 and STAT1, which 
serve as master regulators of host immunity; pattern recognition receptors DDX58 (RIG-
I), IFIH1 (MDA-5) and DHX58 (LGP2), which activate different signaling cascades in 
the innate immune system; type I interferon-stimulated genes ISG15, ISG20, OAS1, 
OAS2, OASL, MX1, IFIT1, IFIT2, IFIT3, HERC5, HERC6, IFI6, IFI35, IFI44 and 
IFI44L, which play a variety of antiviral roles (Schoggins et al., 2011); and the cytokine 
CXCL10, which attracts activated T cells (Dufour et al., 2002).   
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Figure 2.2 Genes showing similar patterns of expression during Lassa virus and 
Marburg virus infection.  
Each point represents the level of expression (measured in log10-normalized read counts) 
of a gene that behaves similarly in both types of infection (increasingly darker shades of 
blue for Lassa, and increasingly darker shades of red for Marburg). Panel (A) represents 
the expression of gene IFI44L in the y axis and the time post-infection in the x-axis. 
Panel (B) condenses the information in (A) and shows additional genes along the x-axis. 
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2.4.4 A subset of genes shows unique patterns of expression in each type of 
infection 
After identifying the subset of genes that made up the common transcriptional 
response, we looked for genes that showed unique transcriptional patterns. To do this, we 
considered genes that 1) showed a statistically significant increase or decrease in their 3 
dpi levels of expression for one type of viral infection but not the other, and 2) increased 
or sustained this difference in expression throughout the later stages of the infection.  
In the Lassa infection group, we detected several genes with distinctly upregulated 
expression (Figure	2.3), including SIGLEC1, a cell adhesion molecule expressed by 
dendritic cells and macrophages (Crocker, Paulson, & Varki, 2007; Izquierdo-Useros et 
al., 2012); TNFSF10 (TRAIL), a death receptor ligand implicated in apoptosis and 
immune response signaling (Johnstone, Frew, & Smyth, 2008); and TNK2, a tyrosine 
kinase implicated in cell spreading and migration (Howlin, Rosenkvist, & Andersson, 
2008). Other genes, like CENPF, ENPP4, and GZMA, a protease responsible for the 
release of cytotoxic T-cell granules (Hink-Schauer, Estébanez-Perpiñá, Kurschus, Bode, 
& Jenne, 2003), were significantly downregulated during Lassa infection in comparison 
to Marburg infection.  
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Figure 2.3 Gene expression patterns during Lassa or Marburg virus infection.  
A few representative genes are shown in each panel representing each category: (A) 
housekeeping genes, genes that uniformly increase or decrease their expression 3 days 
after both infections, (B) genes that show unique patterns of expression during Lassa 
infection, and (C) during Marburg infection. The y-axis represents the average fold 
change in expression when comparing infected and uninfected samples. 
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In the Marburg infection group, we identified a distinct upregulation in the 
expression of genes encoding heat shock proteins (HSPA1B, HSPA1L and DNAJA1), 
the antiapoptotic gene BIRC3, and the immunoglobulin genes IGJ, IGLV10-54, among 
others. We also found genes that showed lower levels of expression during Marburg 
infection when compared to Lassa infection. Examples of these include PLK3, a kinase 
associated with stress response and apoptosis (Bahassi et al., 2002; Xie et al., 2001); and 
NR4A2, a nuclear receptor which has been shown to induce apoptosis when 
downregulated (Ke et al., 2004).  
2.4.5 Validation of infection-specific patterns of expression using microarrays 
and RT-PCR 
We wanted to know if the genes that showed significant differences in each type of 
infection could be used to classify unknown samples. Although we were not able to 
obtain an independent test dataset, we used additional samples from two other studies to 
characterize the host transcriptional response to Lassa and Marburg infection (Malhotra 
et al., 2013; Connor et al. 2015, in press).  This dataset included the 24 samples that we 
measured using RNA sequencing, as well as 26 additional uninfected samples, 12 Lassa-
infected samples and 3 Marburg-infected samples (Figure	2.1A), for a total of 65 
samples, all of which were quantified using Agilent two-color human microarrays. We 
looked at the genes that we had previously identified (using RNA sequencing) as being 
differentially expressed during one of the two infections, and found that the 
measurements from both platforms were highly correlated (0.81 Pearson’s correlation).  
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To understand in more detail the differences in expression reported by RNA 
sequencing and microarrays, we classified a subset of genes into four categories: 
1) Housekeeping genes were those that showed high levels of expression across all 
samples. 2) Early common response genes were those where infected samples showed 
higher levels of expression than uninfected samples, and had similar magnitudes in both 
types of infection 3 days post-infection. 3) Early Marburg-specific response genes 
were those where Marburg-infected samples showed significantly higher (or lower) 
patterns of expression, compared to uninfected or Lassa-infected samples 3 days post-
infection. 4) Early Lassa-specific response genes were those where Lassa-infected 
samples showed significantly higher patterns of expression, compared to uninfected or 
Marburg-infected samples 3 days post-infection. 
To determine if we could use the common and specific genes to distinguish 
between different types of infected samples, we use Primary Component Analysis (PCA) 
reduce the dimensionality of the microarray gene expression values to two dimensions. 
Instead of using every gene in the arrays, we selected a subset of 12 genes that included 
early common response genes, early Marburg-specific response genes and early Lassa-
specific response genes (Figure	2.4).  Reducing the dimensionality of all samples using 
these genes resulted in three clusters: uninfected samples, infected with Lassa virus, and 
infected with Marburg virus. Each of the infected clusters included not only the early-
infected samples, but also those samples taken at later stages of infection. This indicates 
that the expression patterns of these genes are useful indicators throughout both early and 
late stages of infection. 
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Figure 2.4 Primary Component Analysis of Microarray Samples.  
Each point corresponds to an RNA sample. Lassa-infected and Marburg-infected samples 
are shown in increasingly darker shades of blue and red, respectively. Distances between 
points represent the similarity among samples based on the application of Primary 
Component Analysis (PCA) to the microarray expression values of 12 biomarker genes: 4 
common response genes (MX1, OAS1, IFI44L and CXCL10), 4 Marburg-specific 
response genes (HSPA1B, IGJ, HSPA1L and BIRC3) and 4 Lassa-specific response 
genes (SIGLEC1, TNK2, TNFSF10 and NR4A2). Uninfected from each batch are shown 
in two shades of grey. Microarray samples that correspond to the sequencing samples that 
were used to identify the biomarkers genes are shown with a black border.  
 
We then looked at the reported expression levels for these genes in both platforms 
(Figure	2.5). We only used samples that were quantified in both sequencing and arrays to 
ensure that differences in variability would only be related to the platform, not to the 
number of samples. The majority of genes showed similar levels of expression in both 
platforms. The biggest differences came from genes like HSPA1L and IGJ, which 
showed much smaller fold changes in arrays than in sequencing. On average, both highly 
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upregulated and downregulated genes showed fold changes with a 1.5-2 times smaller 
magnitude in arrays when compared to sequencing.  
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Figure 2.5 Biomarker genes quantified using RNA sequencing and microarrays.  
For each gene, the y-axis represents its amount of expression in each RNA sample, and 
the x-axis represents these samples ordered by time of infection, colored in increasingly 
darker shades of blue for Lassa, and red for Marburg. The samples in (A) were quantified 
using RNA sequencing and the fold change represents the log2 difference between the 
average infected and uninfected normalized read counts. The samples in (B) were 
measured using two-color microarrays and the fold change represents the log2 ratio 
between the intensity of the red channel and the green channel (see Methods). 
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 This comparison confirmed that both RNA sequencing and microarrays show 
unique changes in mRNA levels early after infection. This led us to test the hypothesis 
that a more direct RT-PCR analysis of a small number of these sentinel genes would 
show similar patterns of unique regulation, with the advantage that the format of this 
assay could be applied more quickly and cheaply in the field. We chose to analyze the 
expression of two genes, SIGLEC1 and HSPA1B, which showed unique upregulation at 
early stages of Lassa or Marburg virus infection, respectively. RT-PCR assays carried out 
on uninfected samples, and on samples collected 3 days post-infection, showed that there 
was no statistically significant change in SIGLEC1 expression between these two time 
points in Marburg-infected animals, but that there was a 70-fold change in expression in 
Lassa-infected animals. Similarly, HSPA1B showed a minor change in Lassa-infected 
animals, but a 36-fold change in Marburg-infected animals. This confirmed that 
SIGLEC1 becomes upregulated during the early stages of Lassa infection but not 
Marburg infection, while HSPA1B is only upregulated during the early stages of 
Marburg infection (Figure	2.6).  
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Figure 2.6 RT-PCR validation of 3 day post-infection expression values.  
SIGLEC1 and HSPA1B are the genes with the highest fold change differences between 
each virus group 3 days post-infection. The y-axis represents the difference in expression 
between each gene and the constitutively expressed gene BIN2. The RT-PCR reactions 
for each gene were performed in duplicate (n=2). 
 
2.5 Discussion 
 In the work described in this manuscript, we investigated the hypothesis that the 
circulating immune response can be used to aid early diagnosis of viral infections that are 
associated with high levels of mortality. When we analyzed the transcriptional patterns of 
the circulating immune system in response to two different hemorrhagic fever viruses, we 
identified a subset of genes that uniquely increased their rate of transcription 3 days after 
infection and that sustained these differences throughout infection (Figure	2.3). 
 An important aspect of this study was that the uniquely regulated genes were not 
the only genes that changed their patterns of expression during the early times of 
infection (before the detection of clinical symptoms), but that many other genes—pattern 
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transcriptional regulators—also became rapidly upregulated. This suggests that early after 
infection, there is a strong activation of the type I interferon innate immune response. 
This early innate response has also been reported for infections with other viruses, such 
as Ebola (Gupta et al., 2001), influenza (Huang et al., 2011) and respiratory syncytial 
virus (RSV) (Chen et al., 2011), and suggests that the activation of the innate immune 
system is being driven by a different mechanism. Surprisingly, we did not detect a 
significant upregulation of type I interferon genes, although we did see it for their 
downstream effectors. Protein studies indicate that type I interferon is present during 
Marburg virus infection, suggesting that interferon transcription might be localized to 
plasmacytoid dendritic cells, which are not strongly represented in the PBMC population 
(Fritz, Geisbert, Geisbert, Hensley, & Reed, 2008). 
 In addition to the common transcriptional changes that we observed at early times 
of infection, we also identified a number of genes with unique patterns of expression in 
each type of infection. The unique markers of Marburg infection were generally 
classifiable into functional categories, including heat-shock proteins (HSPA1B, HSPA1L, 
DNAJA1) and immunoglobulin-associated genes (IGJ, IGLV10-54). These results 
suggest that the response to Marburg infection leads to the expansion of both stress 
adaptive and immunological maturation pathways at very early times of infection.  
 Some of the most uniquely expressed genes during Lassa infection are SIGLEC1 
(also known as CD169 or sialoadhesin) and TNFSF10 (also known as TRAIL). The 
upregulation of these genes suggests an increase in SIGLEC1+ TRAIL+ macrophages 
early in Lassa infection (Crocker et al., 2007; Russier, Reynard, Tordo, & Baize, 2012; 
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van der Kuyl et al., 2007). A more detailed understanding of the mechanisms leading to 
the unique signatures identified will require further investigation. While both Lassa virus 
and Marburg virus are known to evade antiviral responses by inhibiting the expression of 
specific host genes (Christopher F Basler & Amarasinghe, 2009; Hayes & Salvato, 2012), 
it is unlikely that these mechanisms are directly responsible for the expression differences 
that we found in PBMCs, since they take place during the pre-viremic stages of infection. 
The specific differences observed take place even in the absence of any viral genetic 
material in the PBMCs, which suggests that these circulating cells are responding to an 
external signal. An alternative explanation for the existence of unique signatures might be 
related to each pathogen’s cell tropism: Marburg virus preferentially targets monocytes, 
macrophages, dendritic cells and Kupffer cells (Hensley, Alves, et al., 2011), and leads to 
significant lymphocyte apoptosis (T W Geisbert et al., 2000). Lassa virus targets 
dendritic cells, Kupffer cells, hepatocytes, adrenal cortical cells and endothelial cells 
(Hensley, Smith, et al., 2011), and is not known to induce lymphocyte decreases. It is 
possible that a combination of which cells become initially infected and the magnitude of 
the early response combine to ultimately produce the infection-specific signatures that we 
observe. 
 We have shown that microarrays can be used to validate the changes in 
expression that take place in Lassa- and Marburg-infected PBMCs in addition to RNA 
sequencing. Although the majority of genes that undergo significant early changes in 
expression were highly correlated in both platforms, microarrays showed a smaller range 
of gene expression differences between both types of infected samples and greater 
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variability. Three previous studies that analyzed the immune response to Lassa virus 
infection (Malhotra et al., 2013; Juan Carlos Zapata et al., 2013) and LCMV virus 
infection (Djavani et al., 2007) were in general agreement with the major trends that we 
identified using RNA sequencing: mainly the upregulation of interferon-stimulated genes, 
pattern recognition receptors and pro-inflammatory cytokines. 
 The infection-specific transcriptional changes that we have found suggest a 
method for discriminating between diseases with similar early clinical symptoms, as is 
the case for Lassa and Marburg infection. In infected animals, these transcriptional 
changes take place prior to the appearance of viremia and other overt symptoms 
(Malhotra et al., 2013), and they remain sustained throughout the late stages of infection, 
thereby providing a way to diagnose which virus is most likely causing the infection. 
This diagnosis can be carried out during the early time window when treatment is most 
effective, and before the pathogen starts replicating in the bloodstream on a massive 
scale. To ensure that an RT-PCR-based diagnostic would be able to distinguish between 
diseases other than Lassa and Marburg disease, it would be important to determine the 
host transcriptional response to additional pathogens like influenza virus, dengue virus or 
the malaria parasite, which cause similar initial symptoms to those of viral hemorrhagic 
fevers. 
In conclusion, the expression of a unique set of host genes increases or decreases 
preferentially in Lassa- or Marburg-infected immune cells. During Marburg virus 
infection, heat-shock protein and immunoglobulin genes show significantly greater levels 
of expression than during Lassa virus infection, which is characterized by the 
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upregulation of the cell adhesion molecule SIGLEC1, the death receptor ligand 
TNFSF10, and the tyrosine kinase TNK2. These changes in expression appear early after 
infection and remain sustained throughout the entire course of disease, which provides a 
way to diagnose which virus is most likely to be causing the infection without having to 
wait until the appearance of viremia or other overt symptoms. The fact that these changes 
were identified using multiple platforms (RNA sequencing, microarrays and RT-PCR) 
suggests a path for translating these gene expression profiles into a diagnostic test with 
direct clinical applications. 
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CHAPTER 3  
IN VIVO EBOLA VIRUS INFECTION LEADS TO A STRONG INNATE 
RESPONSE IN CIRCULATING IMMUNE CELLS 
 
3.1 Preamble 
Ebola virus is the causative agent of a severe syndrome in humans with a fatality 
rate that can approach 90%. During infection, the host immune response is thought to 
become dysregulated, but the mechanisms through which this happens are not entirely 
understood. It would be helpful to have a more detailed view about the transcriptional 
changes that take place during infection, especially during the early stage, before the 
virus can be detected in the blood. In this study, we use RNA sequencing to identify the 
gene expression patterns of circulating immune cells from macaques infected with Ebola 
virus. Approximately half of the 100 genes with the strongest early increases in 
expression were interferon-stimulated genes, such as ISG15, OAS1, IFIT2, HERC5, 
MX1 and DHX58. Other highly upregulated genes included cytokines CXCL11, CCL7, 
CCL8, IL2RA, IL2R1, IL15RA, FAS, and CSF2RB, which have not been previously 
reported to change during Ebola infection. Comparing this response in two different 
models of exposure (intramuscular vs. aerosol) revealed a similar signature of infection 
with a time delay in the aerosol model. The strong innate response in the aerosol model 
was seen not only in circulating cells, but also in primary and secondary target tissues. 
Conversely, the innate immune response of vaccinated macaques was almost non-
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existent. This suggests that the innate response is a major aspect of the cellular response 
to infection. 
The viral infections, RNA isolation and sequencing for the group infected via 
intramuscular injection were performed at the University of Washington. The viral 
infections and the RNA isolation for the group infected via aerosol exposure were 
performed at the United States Army Medical Research Institute of Infectious Diseases 
(USAMRIID). The aerosol samples were sent to Boston University, where they were 
prepared for sequencing, and they were sequenced at the Broad Institute. I analyzed the 
results of the RNA sequencing samples for both groups. 
 
3.2 Introduction 
 Infection with Ebola causes Ebola hemorrhagic fever, a disease associated with 
mortality rates between 25-90% (Feldmann & Geisbert, 2011). The earliest clinical 
symptoms are non-specific and flu-like, such as high fever, headache and myalgia 
(Feldmann & Geisbert, 2011; WHO Ebola Response Team, 2014; Wong, Kobinger, & 
Qiu, 2014). During the large outbreak in Western Africa (2014-present), the symptoms 
also included diarrhea and vomiting (WHO Ebola Response Team, 2014). The late stage 
of disease is associated with immune cell imbalances such as neutrophilia and 
coagulation disorders like diffuse intravascular coagulopathy (Bradfute et al., 2010; 
Paessler & Walker, 2013; Reed, Hensley, Geisbert, Jahrling, & Geisbert, 2004). 
Several studies have reported that during infections caused by respiratory and 
hemorrhagic fever viruses, circulating immune cells undergo major gene regulatory 
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changes that result in the upregulation of many innate immune system genes (Caballero, 
Bonilla, Yen, & Connor, 2012; Mejias et al., 2013;  a. K. Zaas et al., 2013; A. K. Zaas et 
al., 2009). One of the most interesting aspects about this surge in transcriptional activity 
is that it constitutes an early measurable indicator of infection. In the present study, we 
use multiple RNA sequencing datasets to understand the gene expression patterns in 
peripheral blood mononuclear cells (PBMCs) of cynomolgus macaques infected with 
Ebola virus. One dataset was generated using macaques infected with Ebola virus that 
had previously been either vaccinated against Ebola or against a different virus. The 
advantage of this dataset is that it provides a unique comparison between Ebola-naïve and 
Ebola-vaccinated animals, and it makes it possible to determine which genes become 
differentially regulated as a direct result of Ebola infection. The other dataset was useful 
to determine the differences in gene expression that are dependent on specific routes of 
infection. Some of the animals were infected with Ebola virus via aerosol, while others 
received an intramuscular injection. A common feature of all of these datasets was that in 
addition to the infected samples, they contained pre-infection controls, which made it 
possible to compare across different studies. 
 
3.3 Materials and Methods 
3.3.1 Macaque model of intramuscular exposure to Ebola virus 
As described in (Marzi et al., 2013), this study used cynomolgus macaques divided 
into two groups: vaccinated and Ebola-naïve. The vaccinated group received an 
intramuscular injection of rVSV/EBOV-GP and, several days later, a lethal dose of 
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EBOV strain Kikwit. The Ebola-naïve group was treated with a non-protective dose of 
rVSV/MARV-GP and, several days later, received the same lethal dose of EBOV 
administered to the vaccinated group. Blood samples were taken at 0, 4 and 7 days post-
infection (n=3 per timepoint/group). PBMCs were isolated from the 18 blood samples 
and RNA sequencing was performed as specified in (Barrenas et al., 2015). The 
sequencing data is available in GEO (Barrett et al., 2013) under accession GSE64538.  
3.3.2 Macaque model of aerosol exposure to Ebola virus 
As described in (Twenhafel et al., 2013), this study used rhesus macaques exposed 
to EBOV via aerosol. 12 PBMC samples were collected at 0, 3, 6 and 8 days post-
infection (approximately n=2 per timepoint). 20 spleen samples were obtained at 0, 1, 3, 
4, 5, 6, 7 and 8 dpi (approx. n=2 per timepoint). 12 adrenal gland samples were obtained 
at 1, 3, 4, 6, 7 and 8 dpi (approx. n=2 per timepoint). 8 axillary lymph node samples were 
obtained at 0, 1, 3, 4, 5 and 6 dpi (approx. n=1 per timepoint). 11 brain samples were 
obtained at 1, 3, 4, 6 and 7 dpi (approx. n=2 per timepoint). 4 liver samples were obtained 
at 0, 3, 5 and 8 dpi (approx. n=1 per timepoint). 3 pancreas samples were obtained at 0, 4 
and 8 dpi (approx. n=1 per timepoint). RNA was extracted from all tissues (including 
PBMCs) and sequenced. The PBMC samples referenced above, as well as 24 additional 
samples taken 1, 4, 5 and 7 dpi (approx. n=4 per timepoint) were also processed using 
microarrays as specified in (J. Y. Yen et al., 2011). The microarray expression data is 
available in GEO under accession GSE68809. 
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3.3.3 Mouse model of exposure to Ebola virus  
 As described in (Cilloniz et al., 2011), this study used BALB/c mice divided into 
two groups. One group was inoculated intraperitoneally with wild-type EBOV. The other 
group was inoculated using the same method, but with mouse-adapted EBOV instead. 
Spleen samples were collected and homogenized at 0, 12, 24, 48 and 72 hours post-
infection from three individuals (n=3) per timepoint. RNA was extracted from the 15 
spleen samples and Agilent microarray processing was performed as specified in 
(Cilloniz et al., 2011). The sequencing data is available in the University of Washington 
Viromics server http://bit.ly/Cilloniz_2011_microarray. 
 
3.3.4 Macaque model of aerosol exposure to Lassa and Marburg virus 
 As described in (Caballero et al., 2014), this study used cynomolgus macaques 
divided into two groups. One group was exposed to LASV Josiah and the other to MARV 
Angola, both via aerosol. RNA was extracted from 24 PBMC samples (n=12 per group) 
and RNA sequencing was performed as specified in (Caballero et al., 2014). The 
sequencing data is available in the Sequence Read Archive (Kodama, Shumway, & 
Leinonen, 2012) under accession numbers PRJNA222891 (Lassa) and PRJNA222892 
(Marburg). 
3.3.5 Fold change analysis of sequencing data 
After the raw sequencing reads of each study were generated, they were trimmed 
and the adapters were removed using Trimmomatic (Bolger et al., 2014). The processed 
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reads were aligned to the Macaca mulatta genome (Ensembl release 77) (Cunningham et 
al., 2014) using TopHat 2.0.11 (Trapnell et al., 2009) with default parameters (segment 
length of 25, allowing up to 2 segment mismatches). Gene counts were obtained using 
HTSeq (Anders, 2010) to count reads that aligned uniquely to each gene. Counts were 
normalized to compensate for differences in library size using the trimmed mean of M-
values normalization method included in the edgeR BioConductor package (Robinson et 
al., 2010).  
A gene was deemed to show statistically significant changes in expression at a 
specific time after infection if the moderated t-test between the infected and pre-infection 
samples resulted in a multiple testing-corrected p-value lower than 0.05, with an absolute 
fold change in expression greater or equal to 3, and an average number of reads across all 
samples greater than 4 counts per million (CPM). When calculating relative changes to 
the pre-infection samples, infected samples were not subtracted from their individual 
uninfected controls (since not every infected sample had a pre-infected control), but from 
an average of all the pre-infection samples. Statistical significance, however, was 
calculated using the individual pre-infection samples, not their average. The Benjamini-
Hochberg algorithm was used to correct the false discovery rate of multiple testing.  
3.3.6 Fold change analysis of microarray data 
Agilent two-color human gene expression microarrays were processed using 
limma (Smyth, 2004). Fold changes were obtained by calculating the log-ratio between 
the intensities of the red channel (corresponding to experimental samples) and the green 
channel (corresponding to Human Universal Reference RNA (Novoradovskaya et al., 
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2004)). These were later background-corrected and normalized using the LOESS 
algorithm. Agilent one-color mouse gene expression microarrays were processed in a 
similar manner as the two-color arrays, but using the reported expression value for each 
probe instead of the log-ratio between the two channels. Benjamini-Hochberg was used 
to correct the false discovery rate of multiple testing. 
 
3.4 Results 
To determine the circulating immune system response to an Ebola virus infection, 
we used sequencing data from PBMCs of cynomolgus macaques infected with Ebola via 
intramuscular injection. Three samples were used from different animals before they 
were infected, 4 days and 7 days after infection, as described in (Barrenas et al., 2015). 
3.4.1 A strong and sustained early host transcriptional response after Ebola 
infection contains many genes associated with the innate immune 
response. 
We observed 128 genes with an 8-fold or higher upregulation by 4 days post-
infection in comparison to the pre-infected samples (with an adjusted p-value of less than 
0.05 and an average of at least 4 read counts per million). By 7 days post-infection, only 
32 of these genes had a downregulated expression. The levels of expression of the other 
96 genes remained constant or increased. Of these, 49 genes are known to be responsive 
to innate immunity transcription factors such as IRF3, IRF7 and STAT1 (also known as 
interferon-stimulated genes, or ISGs) (Schoggins et al., 2011; Uchiumi, Miyazaki, & 
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Tanuma, 2011) (Figure 3.1A) and are herein referred to as canonical ISGs. Figure 3.1A 
shows the log2-fold change of these interferon-stimulated genes at 0, 4 and 7 days post-
infection, highlighting a few representative examples (MX1, ISG15, OAS1, DHX58 
(RIG-I), IFIT2, and HERC5). The other 47 strong and sustained genes show similar 
responses to the ISG group but they have not been previously identified as downstream 
effectors of the interferon response (Figure 3.1B). This population includes several 
neutrophil-associated genes (OLFM4, CD177, SERPINB1, S100P, PTX3 and MMP8), 
suggesting that there is an infiltration of neutrophils in PBCMs during the course of 
infection.  
 
Figure 3.1 Host genes showing strong and sustained changes in expression early 
after Ebola virus infection. 
Each line represents the average fold-change in expression (log2, y-axis) of each gene at 
different times (x-axis) after Ebola infection. Panel A) shows canonical interferon-
stimulated genes while panel B) shows other strong and sustained genes. A representative 
sample of genes is shown in black to illustrate the individual patterns of expression. 
 
To determine if this strong innate immune response was observed in other animal 
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infected with wild type EBOV (which is not pathogenic in mice) and mouse-adapted 
EBOV (which is pathogenic) (Cilloniz et al., 2011). We found that a similar strong ISG 
response was apparent 3 days after infection in both strains, irrespective of pathogenesis. 
We validated these results using expression data from two previous studies that 
infected rhesus macaques with Ebola virus (intramuscular injection) and treated them 
with an anticoagulant drug (recombinant human activated protein C, rhAPC, and 
recombinant nematode anticoagulant protein c2, rNAPc2  (Hensley et al., 2007; J. Y. Yen 
et al., 2011)). We found significant similarity for a majority of early response genes even 
though the expression data was quantified using microarrays. For example, in the rhAPC 
samples, the expression of IFIT2 increased 4 log2-fold and 7.4 log2-fold at 3 and 6 days 
post-infection, respectively; in the rNAPc2 samples the increases were 4.6 log2-fold and 
6.9 log2-fold at 3 and 6 days post-infection, respectively. 
3.4.2 The sustained transcription of early responsive genes is not present in a 
non-productive infection 
To determine if the appearance of an early innate immune response following a 
hemorrhagic fever virus infection was a response to the local damage caused by the initial 
intramuscular injection of a negative strand RNA virus, we compared the innate immune 
response to Ebola virus in animals that had been previously vaccinated against Ebola to 
those that had been immunized against a different hemorrhagic fever virus and were 
therefore susceptible to Ebola virus (Ebola-naïve group). Figure 3.2 shows the changes in 
expression of four canonical ISGs. In the Ebola-naïve group, for example, SIGLEC1 
undergoes a 5.72 log2-fold change 4 days post-infection, while in the vaccinated group 
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the change is only 2.53 log2-fold change. By 7 days post-infection the difference is even 
greater: 7.64 in the Ebola-naïve group, and 3.36 in the vaccinated group. We observe that 
every gene making up the early transcriptional response shows significantly lower levels 
of expression in vaccinated animals in comparison to Ebola-naïve animals.  
 
Figure 3.2: Ebola-naïve and vaccinated responses to Ebola infection.  
Each line represents the average fold-change in expression (log2, y-axis) of MX1, 
RSAD2, SIGLEC1, and IFIT3 at different times (x-axis) after Ebola infection. Panel A) 
shows genes from Ebola-naïve macaques, and Panel B) shows genes from vaccinated 
animals. Panels C) and D) show the fold-change of SIGLEC1 and RSAD2 in vaccinated 
(dashed lines) and Ebola-naïve macaques (solid lines). 
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Figure 2: Ebola-naïve and vaccinated responses to Ebola infec-
tion. Each line represents the average fold-change in expres-
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The expression levels of most cytokines during Ebola infection in vaccinated 
animals remained constant, with the exception of three cytokines that were significantly 
upregulated (CCL7, CXCL10 and CXCL11). These genes mirrored the expression 
patterns seen in the Ebola-naïve animals, but at a lower magnitude (Figure 3.3). For 
example, by 4 days post-infection the expression level of CXCL11 went up 4.5 log2-fold 
in the Ebola-naïve group, but only 2.8 log2-fold in the vaccinated group. 
 
Figure 3.3: Effects of vaccination in the expression of cytokines after Ebola 
infection.  
Each line represents the average expression (log10 counts per million, y-axis) of three 
cytokines that become upregulated in vaccinated animals: CCL7, CXCL10, and CXCL11 
at different times (x-axis) after Ebola infection. IL6 is shown to illustrate the behavior of 
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Figure 3: Effects of vaccination in the expression of cytokines after Ebola 
infection. Each line represents the average expression (log10 counts per 
million, y-axis) of three cytokines that become upregulated in vaccinated 
animals: CCL7, CXCL10, and CXCL11 at different times (x-axis) after Ebola 
infection. IL6 is shown to illustrate the behavior of a cytokine that only 
becomes expressed in Ebola-naïve animals. Genes from Ebola-naïve 
macaques are shown in solid lines while those from the vaccinated animals 
appear in dashed lines.
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a cytokine that only becomes expressed in Ebola-naïve animals. Genes from Ebola-naïve 
macaques are shown in solid lines while those from the vaccinated animals appear in 
dashed lines. 
3.4.3 Cytokine responses during Ebola infection 
In addition to our analysis of early-expressed genes, we were also interested in 
understanding the cytokines expressed during infection. Previous studies have focused on 
a protein-level analysis in the serum and reported an increase in the concentration of a 
number of cytokines after Ebola infection (Ebihara et al., 2011; McElroy & Erickson, 
2014; Wauquier et al., 2010). We observe that a subset of these cytokines reported to be 
present in the serum also show transcriptional upregulations in PBMCs by 4 days post-
infection (IL6, IL1B, IL1RN, CXCL10) and by 7 days post-infection (CCL2, CCL3, 
CSF1, TNF, CXCL1, and CXCL8). Figure 3.4A shows the average fold-change (log2) 
for each of these cytokines on the y-axis, as well as the time after infection when the 
samples were taken on the x-axis. These results suggest a biphasic cytokine response to 
infection. IL1B is the only cytokine with an unusual transcription pattern, peaking at day 
4 and returning to pre-infection levels by day 7. 
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Figure 3.4: Changes in expression of cytokines during Ebola infection.  
Each line represents the average fold-change in expression (log2, y-axis) of each cytokine 
gene at different times (x-axis) after Ebola infection. Panel A) shows ten cytokines that 
undergo strong transcriptional changes and that were previously reported to experience 
changes in serum concentration during Ebola infection. IL1B (dashed stroke) shows a 
transient level of expression, peaking 4 dpi. Panel B) shows seven cytokines that follow 
similar patterns of expressions to those in Panel A) but that have not been previously 
reported to play a role during Ebola infection. 
 
Additionally, we identified several cytokines that were not previously known to 
play a role during Ebola infection. Among these, some became upregulated during the 
early stage of infection (day 4) CCL7, CCL8, CXCL11, IL1R1 and IL15RA, and the ones 
that do so during the late stage of infection (day 7) include the receptors FAS, IL2RA, 
and CSF2RB (Figure 3.4B).  
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3.4.4 The early transcriptional response is common to multiple hemorrhagic 
fevers  
We wanted to compare the early host transcriptional response to Ebola infection to 
the early response that was previously noted in other hemorrhagic fevers (Caballero et al., 
2014). To do this, we used gene expression data from cynomolgus macaques exposed via 
aerosol to either Lassa virus (Caballero et al., 2014; Malhotra et al., 2013) or Marburg 
virus (25, J. H. Connor, submitted), and found that the innate response to both infections 
is highly similar to that of Ebola infection. This is illustrated in Figure 3.5, which shows 
the changes in expression of four canonical ISGs (MX1, ISG15, DHX58 and OAS1) 
during Ebola, Lassa, and Marburg infection. All four genes are significantly upregulated 
at the earliest infected timepoint, and they remain sustained throughout the late stage of 
disease. For example, MX1 goes up 4.7 log2-fold 3 days after Lassa infection, 4.1 log2-
fold 3 days after Marburg infection, and 4.9 log2-fold 4 days after Ebola infection. By 6-
7 days post-infection, the log2-fold changes are 6.1, 6, and 5.4, respectively. By 9-10 
days post-infection, the expression of MX1 seems to decrease mildly in Lassa and 
Marburg infection, but it remains at very high levels compared to the pre-infection 
baseline. During Lassa infection, ISG15 and OAS1 undergo similar expression changes 
to those of MX1: a strong increase, followed by a slight decrease in expression. For 
Marburg and Ebola infection, the early levels of expression of these genes increase more 
rapidly than during Lassa infection, and this trend continues during the late stage of 
disease. These data supports the hypothesis that the immune system responds to different 
viral infections via a common, early, sustained, and strong innate immune response. 
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Figure 3.5: Changes in expression of interferon-stimulated genes during different 
hemorrhagic fever infections.  
Each line represents the average fold-change in expression (log2, y-axis) of MX1, ISG15, 
DHX58 or OAS1 at different times (x-axis) after Ebola (green), Lassa (blue) or Marburg 
(red) infection. 
 
3.4.5 Different routes of infection lead to a similar early transcriptional 
response 
To determine if the route of infection could alter the early transcriptional response 
to Ebola infection, we looked at gene expression data from a study that exposed 
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Figure 5: Changes in expression of interferon-stimulated genes 
during different hemorrhagic fever infections. Each line represents 
the average fold-change in expression (log2, y-axis) of MX1, ISG15, 
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macaques to Ebola virus via aerosol and we compared it to the intramuscular injection 
data. Figure 3.6 shows the expression of twenty genes that have the strongest changes 4 
days post-infection in the intramuscular group (Figure 3.6A), as well as the pattern of 
expression of those same genes under aerosol exposure (Figure 3.6B). RNA sequencing 
was used to quantify the expression in the intramuscular group, while microarrays were 
used for the aerosol group. We find that both groups show a strong increase in expression 
starting at 3-4 days post-infection and increasing during the course of disease.  
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Figure 3.6: Different routes of infection lead to similar transcriptional responses.  
Each line represents the average fold-change in expression (log2, y-axis) of each gene at 
different times (x-axis) after Ebola infection. Panel A) corresponds to intramuscular 
injection (quantified using RNA sequencing), and Panel B) to aerosol exposure 
(quantified using microarrays). Panels C) and D) illustrate the expression observed in two 
individual genes (ISG15 and IFIT2) in the aerosol (dashed) and intramuscular groups 
(solid). 
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3.4.6 The innate immune response takes place across most tissues 
We next compared the expression patterns of the 109 genes that showed the 
strongest upregulation in PBMCs to their expression patterns in multiple tissues in the 
macaque model of aerosol exposure to Ebola virus. We found that the early immune 
response is present across most tissues at varying magnitudes and expression rates. 
Figure 3.7 shows the average expression rate across each tissue type. PBMCs become 
activated at 6 days post-infection (Figure 3.4), and show the strongest activation of all 
tissues at 7 days post-infection. Liver starts becoming activated 3 days post-infection and 
the average expression level continues to increase by 5 and 8 days post–infection. The 
gene expression response in the spleen begins to increase at day 3 and also increases to 
similar levels as in the liver. In the adrenal gland and the pancreas, the expression level 
increases at 4 days post-infection and remains activated until the end of the infection. The 
axillary lymph node is the last to become activated, starting around day 6. The brain 
shows the lowest levels of activation, with a slight increase starting on days 4-6. 
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Figure 3.7: Innate transcriptional response in tissues in an aerosol model of 
infection.  
Grey lines represent the average expression values of the 111 genes most highly 
expressed in PBMCs (grey line). Black lines represent the average expression across all 
tissues for these same genes. The y-axis represents log10 read counts per million, and the 
x-axis different times after infection. 
 
 
3.5 Discussion 
One of the most significant results from our analysis of the PBMC response to 
Ebola infection was the strong activation of innate immune response genes at early times 
post-infection, most of which are classified as interferon-stimulated genes (ISGs). This 
finding is consistent with other analyses of host responses to different viral infections 
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(Caballero et al., 2014; Fink et al., 2007; A. K. Zaas et al., 2009), but in the case of Ebola 
infection, it is an unexpected result. Previous studies have shown that Ebola virus 
infection in vitro blocks the expression of ISGs in liver cells (Hartman, Ling, et al., 2008; 
Kash et al., 2006). This interferon-antagonism is based on the ability of VP35 to block 
the activation of IRF3, which inhibits the expression of interferon beta and other ISGs. 
Mutation of VP35 in a manner that allows IRF3 signaling has been studied in mice 
(Hartman, Bird, et al., 2008) and guinea pigs (Prins et al., 2010) using a recombinant 
Ebola strain containing a single-point mutation in VP35 (R322A). This mutation reduced 
the virus’s ability to replicate and prevented it from inhibiting the interferon response in 
vitro and from leading to pathogenesis in these animal models. These studies are 
consistent with the hypothesis that Ebola virus causes a systemic inhibition of the 
interferon response.  
A caveat of these studies is that they did not measure the innate immune response 
during in vivo wild type Ebola virus infection. Our analysis shows that almost all tissues 
examined (with the exception of the brain) undergo a strong expression of interferon-
stimulated genes. This implies that an innate immune trigger of IRF3 or interferon 
signaling is expressed and released into the circulation. Our analysis supports the 
hypothesis that unlike what happens in an in vitro infection, Ebola virus infection leads to 
a robust, early, and global innate response in vivo.  
An explanation for why we detect a significant increase in the expression of IRF3 or 
interferon-stimulated genes at the early stages of Ebola infection could be that infected 
cells stimulate uninfected neighboring cells to produce interferon through a currently 
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unknown mechanism, and that this stimulates them to express ISGs and to continue 
spreading the interferon signal ( 
Figure 3.8A). Since we see viral titers and ISG expression increasing throughout 
infection, further studies are required to understand if the populations of cells that are 
expressing ISGs are different from the ones that are undergoing viral replication. Another 
hypothesis is that, in vivo, some cells may retain their ability to translocate IRF3 to the 
nucleus and to express interferon, perhaps due to a missing VP35 ( 
Figure 3.8B). This is consistent with earlier reports showing that there are early 
immune-associated transcriptional responses in primary target cells exposed to either 
Ebola virions or VLPs (Wahl-Jensen et al., 2011). 
 
Figure 3.8: Model for the expression of interferon-stimulated genes during Ebola 
infection.  
A) Ebola-infected cell (top) is not able to produce interferon due to the VP35-inhibition 
of IRF3 translocation. We suggest that the infected cell, through an unknown mechanism, 
might be able to induce neighboring cells (middle) to translocate IRF3 to the nucleus and 
start producing interferon. Once interferon is released by neighboring cells, it activates 
the receptors of additional cells (bottom) and leads to the transcription of ISGs. B) An 
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Figure 8: Model for the expression of interferon-stimulated genes during Ebola infection. A) Ebola-in-
fected cell (top) is not able to produce interferon due to the VP35-inhibition of IRF3 translocation. We 
suggest that the infected cell, through an unknown mecha ism, might b  able to ind ce neighboring 
cells (middle) to translocate IRF3 to the nucleus and start producing interferon. Once interferon is 
released by the neighboring cells, it activates the receptors of additional cells (bottom) and leads to 
the transcription of ISGs. B) An alternative model is that some cells (top) can become infected with 
Ebola VLPs, which are not able to block IRF3 translocation, and therefore they can produce interfer-
on, release it to neighboring cells (middle and bottom) nd they in turn start transcribing ISGs.
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alternative model is that some cells (top) can become infected with Ebola VLPs, which 
are not able to block IRF3 translocation, and therefore they can produce interferon, 
release it to neighboring cells (middle and bottom) and they in turn start transcribing 
ISGs. 
 
One of the hallmarks of Ebola infection is dysregulated levels of circulating 
proinflammatory cytokines. We observed the levels of expression of previously reported 
cytokines such as IL6, and CXCL8 (IL8) increase between 4 and 7 days post-infection. 
We also found several cytokines, such as CCL7 and CXCL11 (I-TAC), that showed 
significant changes in expression but whose protein levels have not been previously 
measured during Ebola pathogenesis. CXCL10 (IP-10) and CXCL11 were two of the 
cytokines that showed a significant increase in expression in vaccinated macaques 
infected with Ebola virus. This suggests that they are part of a conserved response in both 
the pathogenic and non-pathogenic response to Ebola. Both cytokines are induced by 
interferon alpha (ISGs), share a common receptor (CXCR3), and are thought to be 
involved in the recruitment of effector T cells and NK cells (Groom & Luster, 2011). 
They are also known to be induced during the acute phase in other types of viral 
infections including dengue (Hsieh et al., 2006), influenza (Fadel, Bromley, Medoff, & 
Luster, 2008), hepatitis B and C (Dufour et al., 2002; Zeremski et al., 2008), Herpes 
simplex (Nakanishi, Lu, Gerard, & Iwasaki, 2009) and HIV-1 (Brainard et al., 2007). 
Upregulation of CXCL10 has also been associated with hemorrhagic manifestations in 
patients infected with Sudan virus (McElroy & Erickson, 2014). Our analysis suggests 
that these cytokines may be part of an innate immune response that is seen in both 
vaccinated and Ebola-naïve animals. 
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By comparing how different routes of infection affect the cellular circulating 
immune response in Ebola-infected primates, we observed that infection via an aerosol 
and via intramuscular (IM) injection resulted in similar patterns of gene expression. Since 
the earliest samples taken in each group differed by one day (4 dpi in the intramuscular 
group, and 3 dpi in the aerosol group), it is not possible to determine if there was a time 
delay. 
Our results extend earlier observations of a strong innate immune response and 
suggest the involvement of new cytokines in Ebola infection. Further analysis of the cells 
responsible for driving this response and for producing the different cytokine signals will 
be important to understand the ability of the virus to replicate virtually unchecked in 
many tissues, and to identify what cells are undergoing that uncontrolled ISG response. 
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CHAPTER 4  
VALIDATION OF HOST IMMUNE RESPONSES ASSOCIATED WITH VIRAL 
HEMORRHAGIC FEVERS 
 
4.1 Introduction 
Hemorrhagic fever viruses are major human pathogens that often result in severe 
disease and high mortality rates. The mechanisms of pathogenesis of these viruses are not 
well characterized, but they are thought to be caused by the dysregulation of normal host 
immune responses. One method of determining the nature of the host response to 
infection is to identify the gene expression changes in the circulating immune system 
after infection.  
In chapters 2 and 3, I showed that the circulating immune cells of macaques 
infected with Lassa and Ebola virus show strong increases in the expression of interferon-
stimulated genes and other infection-specific genes early after infection. Validating these 
findings requires analyzing independent datasets to ensure that the detected patterns are 
reproducible. In this chapter, I compare the patterns of expression of two datasets: one 
from macaques infected with different strains of the arenaviruses Lassa virus and Lujo 
virus, and another dataset from macaques infected with Ebola virus.  
The greatest strength of the arenavirus dataset is that it makes it possible to 
compare the patterns of expression across three different strains of the Lassa virus, 
including the Josiah strain, which I previously analyzed using RNA sequencing. 
Although this dataset does not have any pre-infection samples, the earliest samples were 
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taken 1 day post-infection. Based on previous analyses, the patterns of expression at this 
time are still very similar to those of pre-infection samples. The main advantage of the 
Ebola dataset is that samples were taken every day between pre-infection and 6 days 
post-infection. This increases the resolution and allows for a more comprehensive view 
of the patterns of expression throughout disease. Unfortunately, the microarray platform 
that was used to quantify this expression is missing probes for several thousand genes, 
and the efficiency of many of the existing probes is likely to not be optimized. Regardless 
of the limitations of these datasets, they can both provide useful information that can be 
used to validate the patterns of expression that are associated with viral hemorrhagic 
fevers. 
 
4.2 Methods 
4.2.1 Macaque model of intramuscular exposure to different Lassa virus strains 
and Lujo virus 
As described in (Rasmussen et al., 2014), cynomolgus macaques were infected via 
intramuscular injection with either Lujo virus or with one of three different Lassa virus 
strains (Josiah (Wulff & Johnson, 1979), Z132 (P B Jahrling, Frame, Smith, & Monson, 
1985; Safronetz et al., 2010), Soromba (P B Jahrling et al., 1985)). Blood samples were 
taken at 1, 4, 7, and 10 days post-infection (n=3 per timepoint/condition). Additionally, 
pre-infection samples were also obtained for the Lujo-infected group. Peripheral blood 
mononuclear cells were isolated from these samples, RNA was extracted and hybridized 
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to Agilent Rhesus macaque one-color microarrays. The microarray data was processed 
using limma (Smyth, 2004) and normalized using LOESS (Smyth & Speed, 2003). The 
raw data is available in GEO (Barrett et al., 2013) under accession GSE49838.  
4.2.2 Macaque model of Ebola virus 
Fifteen cynomolgus macaques were inoculated via intramuscular injection with 
Ebola virus (Rubins et al., 2007). Blood samples were taken before infection and every 
day between days 1 and 6 post-infection. RNA was extracted and hybridized to Agilent 
Rhesus macaque two-color microarrays with probes for 18,000 genes. The microarray 
data was processed using limma (Smyth, 2004) and normalized using LOESS (Smyth & 
Speed, 2003). Expression values were obtained by calculating the log-ratio between the 
intensities of the red channel (which corresponds to experimental samples) and the green 
channel (which corresponds to Human Universal Reference RNA (Novoradovskaya et 
al., 2004)). The raw data is available in GEO (Barrett et al., 2013) under accession 
GSE8317. 
 
4.3 Results 
4.3.1 Infection with different strains of Lassa virus leads to similar host immune 
transcriptional responses 
To determine the effects that different strains of Lassa virus would have in the 
immune response, I compared the host patterns of expression from two different studies 
where macaques were infected with different Lassa virus strains. The first study used 
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RNA sequencing to quantify the host gene expression of macaques infected with the 
Josiah strain of Lassa virus (Chapter 2, Caballero et al., 2014). The second study used 
microarrays to quantify the expression of macaques infected with one of three strains of 
Lassa virus (Josiah, Soromba and Z132) and Lujo virus, a virus from the same viral 
family as Lassa (Arenaviridae) (Rasmussen et al., 2014).  Only 7 genes, out of the 12 that 
we had previously identified in Chapter 2, have corresponding microarray probes. Figure	4.1 shows the patterns of expression of these genes, along with the housekeeping gene 
TPT1, at several times after infection with the Josiah strain of Lassa virus. The dark blue 
lines correspond to the log2 fold-changes in expression for a specific gene in the RNA 
sequencing dataset, while the light blue lines correspond to those in the microarray 
dataset. OAS1, SIGLEC1 and TNFSF10 are three of the genes that increase their levels 
of expression early after Lassa virus infection. IGJ, BIRC3, TNK2 and NR4A2 are four 
of the genes whose levels of expression remain relatively constant or decrease after 
infection. SIGLEC1 seems to show an increase in expression 3-4 days post-infection in 
both platforms, but the associated microarray probes report a faster decrease of 
expression than that quantified via RNA sequencing. Conversely, IGJ shows a sharp 
decrease in the microarray platform, while the early fold change reported in the RNA 
sequencing study does not appear to vary. 
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Figure 4.1 Gene expression in an independent dataset of samples infected with Lassa 
virus (Josiah strain). 
Each line represents the average fold-change in expression (log2, y-axis) of a gene at 
different times (x-axis) after infection with Lassa virus (Josiah). Dark blue lines represent 
sequencing samples from (Caballero et al., 2014), and light blue lines correspond to 
microarray samples from (Rasmussen et al., 2014).  
 
 Once we identified a high level of agreement between the RNA sequencing and 
microarray platforms for samples infected with the Josiah strain of Lassa virus, we 
looked at two additional Lassa virus strains, Soromba and Z132. Figure	4.2 compares the 
level of expression of these three strains. The dark blue line represents the log2 fold-
change of Josiah-infected samples, quantified using RNA sequencing, the light blue and 
purple lines represent the log2 fold-changes of Soromba-infected and Z132-infected 
samples, respectively. The upregulations of OAS1, SIGLEC1, and TNFSF10 are also 
seen in these two additional strains. Both show very similar patterns except for IGJ, 
BIRC3 and NR4A2, which show slight differences in expression, especially 4 days post-
infection. 
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Figure 4.2 Gene expression in an independent dataset of samples infected with Lassa 
virus (Soromba and Z132 strains). 
Each line represents the average fold-change in expression (log2, y-axis) of a gene at 
different times (x-axis) after infection with Lassa virus. Dark blue lines represent 
sequencing samples infected with Lassa virus (Josiah) from (Caballero et al., 2014). The 
other lines correspond to microarray samples from (Rasmussen et al., 2014). Light blue 
lines correspond to samples infected with Lassa virus (Z132). Purple lines correspond to 
samples infected with Lassa virus (Soromba). 
 
 Finally, we wanted to determine how these similarities that we identified across 
three different strains of Lassa virus would compare to the patterns of expression of a 
different arenavirus. Figure	4.3 shows the same genes as in the previous figures, but it 
compares Josiah-infected samples quantified using RNA sequencing with those infected 
with Lujo virus and quantified using microarrays. OAS1 shows a similar pattern of 
upregulation as that seen in the different Lassa strains, but SIGLEC1 and TNFSF10 show 
lower-magnitude and time-delayed upregulations compared to the Lassa strain values. 
The low-expression genes show similar patterns of transcription after Lujo virus and 
Lassa virus infection. 
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Figure 4.3 Gene expression in an independent dataset of samples infected with Lujo 
virus. 
Each line represents the average fold-change in expression (log2, y-axis) of a gene at 
different times (x-axis) after infection. Dark blue lines represent sequencing samples 
infected with Lassa virus (Josiah) from (Caballero et al., 2014). The other lines 
correspond to microarray samples from (Rasmussen et al., 2014). Orange lines 
correspond to samples infected with Lujo virus. 
 
 The large fold changes in the expression of these genes after infection indicate 
strong transcriptional differences between uninfected and infected samples. To determine 
the magnitude of these differences, we applied Primary Component Analysis to the levels 
of expression of these seven genes and found a clear difference between both groups.  Figure	4.4 shows each sample as a point, and the distances between them represent a 
measure of the level of similarity among the samples. The first two principal components 
explain 84.46% of the variance of the dataset, and show a clear separation between the 
uninfected sample cluster (in grey) and the infected samples (in colors), which do not 
separate into any distinguishable clusters using these markers. 
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Figure 4.4 Primary Component Analysis of an independent dataset of Arenavirus 
microarray samples. 
Each point corresponds to an RNA sample from (Rasmussen et al., 2014). Lassa-infected 
samples are shown in shades of blue and purple (Josiah, Z132, and Soromba strains). 
Lujo-infected samples are shown in orange. Uninfected samples are shown in grey. 
Distances between points represent the similarity among samples based on the 
application of Primary Component Analysis (PCA) to the microarray expression values 
of 7 genes previously identified to be upregulated after Lassa virus infection: OAS1, IGJ, 
BIRC3, SIGLEC1, TNK2, TNFSF10, NR4A2.  
 
4.3.2 Ebola virus infection leads to the production of robust patterns of host 
gene expression  
To determine if the transcriptional patterns that we identified in Chapter 3 could be 
reliably detected in an independent study, we analyzed data from a previous study that 
infected macaques with Ebola virus and used microarrays to measure their gene 
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expression responses after infection (Rubins et al., 2007). We compared these responses 
those reported in (Barrenas et al., 2015), which also infected macaques with Ebola virus, 
but used RNA sequencing to quantify the post-infection patterns of expression.  Figure	4.5 shows the log2 fold-changes in expression throughout infection of multiple genes in 
both datasets. The dark green lines correspond to gene expression changes quantified by 
RNA sequencing, while the light green lines correspond to expression changes quantified 
by microarrays. Only genes with corresponding microarray probes were chosen. The 
Actin B gene (ACTB) is shown first for reference. MX1 and OAS1 are two interferon-
stimulated genes that increase quickly and strongly after viral hemorrhagic fever 
infection. TNFSF10, VCAN, TNK2 and BIRC3 are genes that show an increase in 
expression around 4 days post-infection in both the sequencing and microarray datasets. 
Conversely, IGJ shows a decrease in expression in both platforms. The genes HSPA1L, 
S100A8, HSPA1B and ADAM28 appear to become strongly upregulated in the 
sequencing dataset, but this upregulation is not present when the data is quantified using 
microarrays. 
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Figure 4.5 Gene expression in an independent dataset of samples infected with 
Ebola virus. 
Each line represents the average fold-change in expression (log2, y-axis) of a gene at 
different times (x-axis) after infection with Ebola virus. Dark green lines represent 
sequencing samples from (Barrenas et al., 2015). Light green lines correspond to 
microarray samples from (Rubins et al., 2007).  
 
 Although comparing the sequencing and microarray datasets showed large 
discrepancies in the expression values of several genes, we wanted to know if the 
expression values of this set of genes could be used to distinguish between infected and 
uninfected samples. To verify this, we applied Primary Component Analysis to the levels 
of expression of these eleven genes and identified a clear difference between both groups. Figure	4.6 shows each sample as a point, and the distances between them represent a 
measure of the level of similarity among the samples. The first two principal components 
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explain 79.38% of the variance of the dataset and show two clear clusters. The first 
cluster is composed of uninfected samples (in grey) and infected samples obtained 1-2 
days post-infection (increasingly darker shades of green), before the host transcriptional 
response gets activated. The second cluster is composed of infected samples obtained 3-6 
days post-infection (increasingly darker shades of green), with the 3 dpi samples situated 
between both clusters along the first principal component (x-axis). 
 
 
Figure 4.6 Primary Component Analysis of an independent set of Ebola microarray 
samples. 
Each point corresponds to an RNA sample from (Barrenas et al., 2015). Ebola-infected 
samples are shown in increasingly darker shades of green. Uninfected samples are shown 
in grey. Distances between points represent the similarity among samples based on the 
application of Primary Component Analysis (PCA) to the microarray expression values 
of 11 genes previously identified to be upregulated after Ebola virus infection: MX1, 
OAS1, HSPA1B, IGJ, HSPA1L, BIRC3, TNK2, TNFSF10, ADAM28, VCAN, and 
S100A8. 
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4.4 Discussion 
I previously identified a set of genes that undergo unique patterns of expression 
early after infection with a hemorrhagic fever virus. To ensure that this transcriptional 
patterns could be reliably detected across a number of experimental conditions, I 
analyzed two publicly available datasets of cynomolgus macaques infected with different 
strains of Lassa virus, Lujo virus, or Ebola virus, and compared the patterns of expressing 
of a subset of genes to those that showed significant changes in expression in the original 
datasets (Chapters 2 and 3). 
Comparing the sequencing and the microarray datasets for the Lassa Josiah strain 
showed strong agreement in genes that increase 3-4 days post-infection, as well as among 
genes that remain constant or decrease after infection. A similar result was seen for Lassa 
Soromba and Z132 strains. The Lujo virus immune response showed similar patterns of 
upregulation compared to the response to Lassa virus, but with a delay of 72-hours. This 
is likely a result of the evolutionary distance between both viruses, they are similar 
enough to be classified in the same viral family, but different enough to be distinct 
viruses. Several genes that showed strong patterns of infection in the Lassa sequencing 
dataset could not be compared in the microarray platforms because the corresponding 
probes for these genes were not present.  
In the Ebola dataset, the differences between the gene patterns in the microarray 
and sequencing platforms were larger than in the Lassa dataset. A number of genes 
showed strong agreement (MX1, OAS1), while others did not show similar patterns 
(HSPA1B, ADAM28). Similar to the Lassa dataset, several genes in the Ebola 
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microarrays lacked corresponding probes, and their expression could not be compared to 
the sequencing data. This lack of a unified set of genes, along with imperfect probe-gene 
complementarity, are likely the major factors that explain the lack of agreement between 
both platforms. 
 Comparing both platforms has shown that the genes identified in the sequencing 
datasets can be used to distinguish among infected and uninfected microarray samples 
(Figure	4.4 and Figure	4.6). This provides additional confidence that these patterns are 
strong and reliable indicators of an early immune response against these viruses. 
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CHAPTER 5  
THE MASTER REGULATOR OF THE CELLULAR STRESS RESPONSE IS 
CRITICAL FOR ORTHOPOXVIRUS INFECTION 
 
5.1 Preamble 
In this chapter I describe work that I carried out as part of a collaborative effort to 
define the role of cellular host proteins in poxvirus replication. My contribution to the 
project was to analyze two different RNA sequencing datasets to identify the expression 
of host genes after 4-6 hours post infection with Vaccinia virus. I also compiled a list of 
chaperones and HFS1 targets from previous studies and showed that the majority of 
upregulated genes in both datasets belonged to these categories. The majority of the 
results presented in this chapter were previously published in (Filone et al., 2014). 
 
5.2 Introduction 
The Poxviridae family is comprised of several human pathogens in the 
Orthopoxvirus genus, including monkeypox (MPXV) and smallpox (Variola), which was 
eradicated through vaccination with vaccinia (VACV). With a dramatic increase in 
human MPXV cases in Africa, the rise of VACV-like orthopoxvirus infection in South 
America, and concerns about the weaponization of smallpox, it is important to design 
new strategies for the treatment and prevention of these diseases (Damaso, Esposito, 
Condit, & Moussatché, 2000; Rimoin et al., 2010). To this end, one valuable method to 
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understand the mechanism of disease is to determine the virus-host interactions necessary 
for orthopoxvirus infection. 
Orthopoxviruses are large double-stranded DNA viruses with a unique lifecycle in 
the cytoplasm of the host cell. The viruses enact a cascade of transcriptional responses, 
with early gene expression occurring from the stages of viral entry to uncoating, 
intermediate gene expression after DNA replication, followed by late gene expression 
until the end of the virus lifecycle (Yang et al., 2011; Yang, Bruno, Martens, Porcella, & 
Moss, 2010). Early in infection, orthopoxviruses express factors that cleave host mRNAs, 
effectively preventing the expression of most host genes (Guerra et al., 2003; Yang et al., 
2010). Poxviruses are also known to use host proteins during their lifecycle. This 
includes the use of the proteasome to facilitate viral uncoating and DNA replication, the 
ribosome to translate mRNAs, and specific host factors to help drive late viral 
transcription events (Becker & Joklik, 1964; Mercer et al., 2012; Satheshkumar, Anton, 
Sanz, & Moss, 2009; Teale et al., 2009). 
Several RNAi screens have been performed in recent years and have expanded 
our knowledge of the host proteins involved in orthopoxvirus replication. Moser et al. 
performed a screen of kinase genes in Drosophila cells and found that modulation of the 
actin cytoskeleton by AMPK is important for VACV entry (Moser, Jones, Thompson, 
Coyne, & Cherry, 2010). Mercer et al. screened the 7,000 genes comprising the 
“druggable genome” and revealed the role of the proteasome in viral uncoating and of the 
Cullin3 ubiquitin ligase in initiating viral DNA replication (Mercer et al., 2012). Finally, 
Sivan et al. performed two siRNA screens targeting over 18,000 genes to reveal the 
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importance of nuclear pore genes in viral morphogenesis (Sivan et al., 2013). All of these 
important new insights were based on an arrayed RNAi screen format. Notably, these 
screens generated hit lists with some overlap on the protein or functional level, but also 
significant numbers of unique hits. This is presumably due to substantial false negative 
rates, false positive rates, and the distinct model systems and readouts used to assess 
VACV infection, suggesting that more host protein factors remain to be discovered. 
Here, we used two complimentary and unbiased assays to identify host proteins 
necessary for orthopoxvirus infection. First, we developed a pooled-cell lentiviral shRNA 
screen in human cells based on screening formats previously utilized to determine 
pathways important in cancer biology (Cheung et al., 2011; Macosko et al., 2015). 
Strengths of the pooled screen format are the ease of scaling to larger screening sets and 
the ability to enable multiple screening paradigms. Furthermore, cells are cultured in 
standard low-throughput format, rather than in multiwell plates, and thus can be easily 
passaged and otherwise manipulated. As a second assay, we used RNASeq to analyze the 
host transcriptional responses elicited by poxviral infection. These data identified host 
mRNAs that were upregulated during infection, suggesting that they may facilitate virus 
infection. 
By comparing the data from these two orthogonal datasets, we identified proteins 
involved in the heat shock response as critical factors for orthopoxvirus infection. In 
particular, we found that heat shock factor 1 (HSF1), the ancient master regulator of the 
cytoprotective heat shock response, is necessary for orthopoxvirus infection. We find that 
depletion and knockout of HSF1 or its pharmacologic inhibition significantly reduces 
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VACV infection. Moreover, the principal targets of HSF1 transcription are upregulated 
during VACV infection, even as global host gene expression is suppressed. Our findings 
define a set of host factors that are necessary for orthopoxvirus infection and suggest that 
poxviruses have evolved to utilize host stress responses to their own advantage. 
 
5.3 Materials and Methods 
5.3.1 Cell Culture and Viruses 
A549 cells (CCL-85), HFF-1 (SCRC-1041) and HeLa (CCL-2) cells were obtained 
from the ATCC. The VACV used in this study was strain Western Reserve or a 
derivative thereof (K. Dower et al., 2012; Ken Dower, Rubins, Hensley, & Connor, 
2011). MPXV experiments were completed with modified MPXV Zaire 1979 at 
USAMRIID under appropriate containment conditions (Johnston et al., 2012). 
5.3.2 Pooled shRNA Screen 
Screen. A549 cells were infected in 4 replicates with the lentiviral 90,000 shRNA 
library from the Broad Institute 
(http://www.broadinstitute.org/rnai/public/resources/screening) (Whittaker et al., 2013). 
Cells were counted and resuspended at 1.44E8 cells/replicate in media with 4 mg/ml 
polybrene solution. 1 ml of the cell/ polybrene mixture was put into each well of a 12 
well plate (12 plates total). 50 ml lentivirus library was added to each well and spun at 
2000 rpm (9306g) for 1 hour at room temperature. This concentration gave an infection 
rate of 28%. Plates were incubated at 37uC overnight. The next day, cells were 
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trypsinized and each replicate was pooled into T225 flask. Cells were allowed to sit at RT 
for 30 min, then incubated at 37uC for 1 hour before adding puromycin for selection. 
Cells were selected for 5 days; on day four pools were counted and split into 3 flasks for 
1E8 cells/replicate (12 flasks total). On day 5, cells were infected with VACV-A4L at an 
MOI 5 for 12 hours. Cells were fixed with 4% formaldehyde, washed and resuspended in 
FACS buffer (PBS, 1% BSA, 0.05% sodium azide). Fixed cells were sorted on a MoFlo2 
(Beckman Coulter) cell sorter; Venus-negative cells were collected with gates set on a 
control uninfected cell population. Collected cells were processed for sequencing as 
follows. 
Illumina deep sequencing method. The shRNA region from the integrated 
lentiviral genome was PCR amplified from the purified cellular genomic DNA using the 
following conditions: 5 uL primary PCR primer mix, 4 mL dNTP mix, 16 Ex Taq buffer, 
0.75 mL of Ex TaqDNA polymerase (Takara), and up to 3 mg genomic DNA in a total 
reaction volume of 50 mL. Up to 5 primary reactions were carried out in parallel for each 
sample. Thermal cycler PCR conditions consisted of heating samples to 95uC for 5 min; 
15 cycles of 94uC for 30 sec, 65uC for 30 sec, and 72uC for 20 sec; and 72uC for 5 min. 
PCR reactions were then pooled per sample. A secondary PCR step was performed 
containing 5 mM of common barcoded 39 primer, 8 mL dNTP mix, 16 Ex Taq buffer, 1.5 
mL Ex Taq DNA polymerase, and 30 mL of the primary PCR mix for a total volume of 
90 mL. 10 mL of independent 59 barcoded primers were then added into each reaction, 
after which the 100 mL total volume was divided into two 50 mL final reactions. Thermal 
cycler conditions for secondary PCR were as follows: 95uC for 5 min; 15 cycles of 94uC 
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for 30 sec, 58uC for 30 sec, and 72uC for 20 sec; and 72uC for 5 min. Individual 50 mL 
reactions were then re-pooled. Reactions were run on a 2% agarose gel and intensity-
normalized. Equal amounts of samples were mixed and gel-purified using a 2% agarose 
gel. Samples were sequenced using a custom sequencing primer using standard Illumina 
conditions. 
5.3.3 Arrayed shRNA Secondary Screen 
A549 cells were seeded in 96-well plates at low density the previous day. The 
lentivirus vectors were added to each well to achieve an MOI ,1. Infection was allowed to 
proceed overnight, then puromycin selection was applied for 5 days. The knockdown 
cells were infected with VACV-LREV at MOI 1 or 0.01. Cells were fixed with 4% 
formaldehyde 16–19 hpi, then read on a Tecan infinite M1000 for Venus (excitation: 515 
nm and emission: 528 nm) and mCherry (excitation: 587 nm and emission: 610 nm). The 
secondary screen was completed with 3 independent experiments. Each plate was 
background corrected by subtracting the average of empty wells and normalized to 100% 
by the total RFU across the plate for early and late. An example plate had an average 
early Venus signal of 20,000 RLU, with an average background around 700 RLU and a 
reading of the GFP shRNA of 4,000 RLU. The average late mCherry signal was 3,200 
RLU, with an average background signal around 75 RLU and an example positive hit of 
1300 RLU. The hits were determined by comparing the normalized data across all three 
replicates for hairpins that decreased fluorescence more than 50%. 
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5.3.4 Cell Viability Assay 
A549 cells were seeded in 96-well plates the previous day and infected with the 
arrayed lentiviral vectors at MOI ,1. After 5 days of puromycin selection, the cells were 
lysed and luciferase read according to manufacturer’s instructions using CellTiter-Glo 
Luminescent Cell Viability Assay system (Promega) on a LUMIstar Omega luminometer 
(BMG Labtech) for 1 second/well. 
5.3.5 Immunoblot 
A549 cells were infected at an MOI specified in text. At times indicated, cells were 
lysed in RIPA buffer with protease and phosphatase inhibitors (1 mM PMSF, 1 mM 
benzamidine, 100 nM okadaic acid, 100 nM microcysin and 100 nM sodium fluoride). 20 
mg of total lysate were separated on a 4–15% SDS-PAGE gel and transferred to PVDF 
(Bio-Rad 162-0177). Blots were probed with polyclonal antibodies specific to HSP27 
(abcam [G3.1] antibody ab2790), Virostat anti-VACV virion (Virostat 8101), VACV I3L 
(mAb 10D2, generous gift of Dr. David Evans, University of Alberta, Edmonton), HSF1, 
including anti-HSF1 (phospho S326) (HSF1-PS326; abcam [EP1713Y] ab76076), anti-
HSF1-J7F9 (abcam [J7F9] ab115303), anti-HSF1 (phospho S303) (abcam ab47369), and 
anti-HSF1 #4356 (Cell Signaling). 
5.3.6 Vaccinia Infections with Inhibitors 
A549 or HeLa cells were seeded in 96-well plates the previous day and infected 
with modified VACV viruses as specified in the text at an MOI of 1 (fluorescence 
readout) or 0.1 (viral titer). For drug treatment, compounds were added at specified 
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concentrations prior to virus addition. Inhibitor compounds: Triptolide, Quercetin (Tocris 
Bioscience), KRIBB11 (EMD Millipore), KRIBB3, Pifithrin-m, Myricetin (Sigma 
Aldrich), and Heat Shock Protein Inhibitor I/KNK437 (Santa Cruz Biotechnology, Inc.) 
For fluorophore assays, cells were fixed at 18 hpi with 4% formaldehyde. Plates were 
read on a Tecan infinite M1000 for Venus (excitation: 515 nm and emission: 528 nm) 
and mCherry (excitation: 587 nm and emission: 610 nm). For plaque assays, virus was 
collected 24 hpi and titered by plaque assay. 
5.3.7 Plaque Assay 
Virus was collected at specified timepoints post infection. Virus was freeze/thawed 
and sonicated 36. Viruses were then serially diluted in 10 fold dilutions and added to 
confluent BSC-40 cells. 24–48 hours post infection, cells were fixed and stained with 
crystal violet to visualize plaques. 
5.3.8 Immunofluorescence 
HFF-1 or A549 cells were seeded on coverslips the previous day and infected with 
VACV at MOI 1, mock infected or heat shocked for 2 hours (HFF-1) or 1 hour (A549) at 
42uC. VACV and mock cells were fixed at 5 hpi (HFF-1) or 24 hpi (A549) with 4% 
formaldehyde. Heat shocked cells were recovered at 37uC for 30 minutes (HFF-1) or 1 
hour (A549), then fixed. Cells were stained for HSF1 with HSF1-phospho-S326 or 
HSF1-phospho-S303 and DAPI to delineate nuclei. Coverslips were mounted using 
ProLong Gold antifade reagent with DAPI (Invitrogen) and imaged on Axiovert 200M 
microscope (Zeiss). 
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5.3.9 Host Transcriptome RNASeq 
HeLa cells were grown to 90–100% confluency in 6-well plates, then inoculated 
with VACV-WR (MOI 10) in DMEM+2% FBS, and incubated at 37uC for 1 hour. After 
the 1 hour incubation, virus was removed and cells were washed three times with PBS 
before fresh media (with 2% FBS) was added (0 hpi time point) and returned to 37uC. At 
each time point (0, 0.5, 2, 6, 18 hpi), cells from two wells were harvested for nucleic acid 
extraction. RNA isolation: Total RNA was extracted from cells at each time point with 
Trizol, following the manufacturer’s instructions. cDNA Library preparation: We used 
the Illumina mRNA seq V2 protocol (April 2008) to generate the cDNA library for next-
generation sequencing. In short, mRNA was purified from the total RNA samples and 
fragmented before proceeding with reverse transcription. Adapters were ligated to the 
resulting cDNA fragments. Templates were size-selected through gel purification, then 
enriched by PCR, and the resulting libraries were validated on an Agilent Bioanalyzer 
DNA 1000 chip. 
5.3.10 RNASeq Analysis 
Sequencing. Sequencing five samples of HeLa cells infected with VACV using 
the Illumina platform generated an average of 16 million single-end 36-base pair reads. 
The sequencing data is available at the Sequence Read Archive under accession number 
SRP026257 (http://trace.ncbi.nlm.nih.gov/Traces/sra/sra. cgi?study = SRP026257) Yang 
et al had previously sequenced an additional five samples (WTA-A experiment) using the 
SOLiD platform and generated an average of 41 million single-end 50-base pair reads. In 
both datasets, the reads were aligned to the human genome (version hg19) using TopHat 
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(Kim et al., 2013), as specified in 
https://github.com/nachocab/vaccinia_filone_2013/blob/master/sequencing.sh. 
Differential expression. We calculated the total number of reads that aligned to 
each protein-coding gene specified in GENCODE v14 (Harrow et al., 2012), normalized 
it using the Trimmed Mean M-values method (Robinson et al., 2010), and considered 
each count to represent the amount of expression for a specific gene at a given timepoint. 
We compared the counts at 6 hours post-infection with the pre-infection counts and 
ranked the genes in two dimensions: by fold change and by average abundance (Figure	5.6). This helped us establish two reasonable cutoffs to determine strongly upregulated 
genes (fold-change greater than 2, and normalized counts at 6 hpi greater than 20). 
Additionally, we selected upregulated genes that were also previously identified as HSF1 
target genes by (Mendillo et al., 2012). 
The code is available at https://github.com/nachocab/vaccinia_filone_2013/. 
5.3.11 Monkeypox Infection 
A549 cells were seeded in 96 well plates the previous day. Cells were infected 
with shRNA lentiviruses at MOI ,1 overnight, then selected with puromycin for 3 days. 
Cells were infected with modified MPXV (Johnston et al., 2012) at MOI 1 for 48 hours. 
Cells were fixed with 10% neutral buffered formalin, then read on a SpectraMax M5. 
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5.4 Results 
5.4.1 Pooled RNAi Screen to Identify Host Factors Necessary for Orthopoxvirus 
Infection 
To identify host factors necessary for orthopoxvirus infection we completed a 
whole-genome scale, pooled RNAi screen using lentiviral vectors. This method delivered 
,90,000 short hairpin RNAs (shRNAs) with 5 or more independent shRNAs targeting 
,17,000 human genes to our target cells (Figure	5.1) (Whittaker et al., 2013). Human 
A549 cells were transduced in four replicates with the shRNA lentivirus library at a 
multiplicity of infection (MOI) of #1 to generate cell populations with predominantly no 
more than one shRNA expressed in each cell. Non-transduced cells were eliminated 
following selection with puromycin. Each replicate was then infected at an MOI of 5 with 
a modified vaccinia virus (VACV) that expressed a fusion of the core protein A4L and 
Venus yellow fluorescent protein (K. Dower et al., 2012). This dose of VACV infected 
100% of control cells at 12 hours (data not shown). At 12 hours post infection (hpi), cells 
were fixed and sorted for Venus-negative cells, with gates set on uninfected cells to 
collect Venus-negative pools. This population was selected to enrich for cells in which a 
host protein essential for orthopoxvirus replication, but not essential for host cell survival, 
had been suppressed. 
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Figure 5.1 Pooled-cell shRNA screen revealed host factors necessary for 
orthopoxvirus infection.  
Schematic of the primary pooled shRNA screen.  
 
To determine which host genes were being suppressed in the Venus-negative 
cells, the cell population was analyzed to resolve hairpin sequences that were enriched in 
abundance, in essence using the hairpin sequence as a barcode to indicate shRNA 
treatment. The abundance of each hairpin was assessed by next generation sequencing 
(Ashton et al., 2012) using the Illumina GAIIx system. For each replicate, hairpins with 
fewer than 15 raw reads were not considered. The remaining hairpins were normalized to 
the total read depth for each individual replicate to eliminate variation in read depth 
across replicates. The fold-change enrichment of each hairpin within the Venus-negative 
sorted cells was determined by comparison to the initial abundance of each hairpin 
observed in the plasmid DNA pool used to generate the pooled lentivirus library. These 
fold changes were used to rank the enrichment of each hairpin in the Venus-negative cell 
population in each replicate. Using the RIGER (Luo et al., 2008) algorithm within the 
Gene-E software tool (http://www.broadinstitute.org/cancer/software/ GENE-E/), the 
weighted-second-best metric was used to rank the enriched target genes within each 
replicate. This method uses the pre-calculated ranked hairpin lists for each replicate, and 
then ranks the candidate genes based on the first and second most enriched hairpin for 
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each gene in each replicate. Therefore, at least two hairpins against each gene were 
enriched in the original screen, providing evidence for the specificity of the target gene in 
VACV infection. The target genes identified in the top 500 genes in each replicate were 
considered candidate hits (Table S1). 
To better understand the candidate hits from our screen, we categorized the 
cellular pathways represented in our dataset for both functional pathways and biological 
process gene ontology (GO) terms. First, we used Ingenuity Pathway Analysis (IPA) to 
analyze the functional and signaling pathways associated with these host genes. We 
found that genes associated with molecular transport, ion transport and apoptosis were 
significantly overrepresented. The top categories overrepresented in our dataset correlate 
well with those identified in other screens for host genes important during vaccinia 
infection, with cell death and survival (p = 1.27E-06) and cell morphology (p = 3.17E-05) 
being significantly overrepresented in both screens analyzed using these parameters 
(Sivan et al., 2013). These data indicate that the candidate host factors necessary for 
orthopoxvirus infection are varied, and that several host biological processes act to 
promote orthopoxvirus infection. 
From the initial list of candidate genes identified in our primary screen, a subset 
of 172 genes was selected for a secondary screen in arrayed format with a different 
VACV reporter virus system. In the secondary screen, 5–7 distinct shRNAs targeting 
each gene of interest were used to assess the effect of decreased host protein expression 
on VACV early and late gene expression. The shRNA lentiviral vectors were arrayed in a 
96 well plate format, with a different shRNA in each well. A549 cells were transduced at 
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an MOI of ,1 with the lentivirus vectors expressing each shRNA, selected with 
puromycin for lentiviral integration, and then infected with a modified vaccinia virus that 
expressed soluble Venus under an early promoter and soluble mCherry under a late 
promoter (VACV-LREV) (K. Dower et al., 2012; Ken Dower et al., 2011). Cells were 
fixed 20 hours post VACV-LREV infection and fluorescence was measured from each 
well (Figure	5.2). The secondary screen was carried out with 3 independent biological 
replicates. 
 
 
Figure 5.2 High confidence hits identified in secondary screen.  
Schematic of arrayed shRNA lentivirus secondary screen. 
 
Genes were considered hits if shRNA expression led to at least a 50% decrease in 
either early or late virus promoter-dependent fluorescence production (1) with more than 
one hairpin in a replicate or (2) in at least 2 replicates of the secondary screen without 
significant toxicity to the cells, as determined independently by cell viability assay 
(CellTiterGlo; data not shown). In most cases, knocking down host factors with shRNA 
blocked VACV-LREV late gene expression and not early expression, indicating that the 
host genes were not necessary for VACV entry and early gene expression. We compiled 
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a list of 34 genes that validated in the secondary screen (20% of those tested; Table S4). 
There were 7 genes that were positive hits in all replicates of the secondary screen: 
transcriptions factors HSF1 and SKI, the integrin binding protein ITGB1BP1, the 
aminophospholipid transporter ATP8B1, the Notch ligand JAG1, the nuclear transporter 
TNPO3 and the chemokine receptor CCR9. We considered these seven positives the 
highest-confidence hits emerging from the initial pooled RNAi screen. 
5.4.2 Deep RNA Sequencing to Identify Host Cell Transcriptome during 
Orthopoxvirus Infection 
Among the pooled RNAi screen hits, as well as previously published RNAi screen 
hits, were a large number of proteins that localize to the nucleus, including transcription 
factors, suggesting that VACV requires host systems that operate in the nucleus for its 
own replication (Mercer et al., 2012; Sivan et al., 2013). To investigate the effects of 
VACV infection on transcriptional responses, we analyzed host mRNA expression 
6hours post VACV infection using RNASeq (Figure	5.3A). For each gene, we calculated 
the difference in normalized read counts (from the Illumina sequencing) between the pre-
infection and the 6 hpi samples and compared it with the average number of Illumina 
read counts across these samples. Consistent with prior reports of a profound suppression 
of host mRNA following VACV infection, we also saw an overall decrease in the amount 
of host mRNA (Becker & Joklik, 1964; Guerra et al., 2003; Yang et al., 2010). After the 
normalization protocol, most genes showed a decrease or no difference in expression 
(genes in gray; Figure	5.3B). In contrast, 611 host genes were upregulated during VACV 
infection, as defined by at least a two-fold change in transcript abundance at 6 hours 
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(genes in black; Figure	5.3B). We consider these genes to be actively expressed during 
VACV infection to counteract the nonspecific decay of host mRNA during poxvirus 
infection (Guerra et al., 2003; Parrish & Moss, 2007; Parrish, Resch, & Moss, 2007; 
Yang et al., 2010). 
 
 
Figure 5.3 Host mRNA transcripts upregulated during VACV infection.  
(A) Schematic of RNASeq Experiment. (B) Dots represent the change in expression of 
genes from 0 to 6 hpi (x-axis) and the average number of sequencing reads that align to 
each gene in both timepoints (y-axis). Genes with a fold change greater than 2 and more 
than 20 counts at 6 hpi are considered upregulated (black). HSF1-regulated genes 
upregulated during VACV infection are labeled in red (a subset is labeled with gene 
names). (C) Same analysis as in (B) using the WTA-A dataset at 4 hpi from (Yang et al., 
2010). 
 
We examined the upregulated genes for transcription factor targets (TFT) and GO 
biological process terms using the Molecular Signatures Database (MSigDB) 
(Subramanian, Tamayo, Mootha, Mukherjee, & Ebert, 2005). Strikingly, the set of 611 
upregulated genes was very strongly enriched for genes regulated by HSF1 (p = 3.39E-
15) and the stress response (p = 1.44E-14). Because HSF1 was also one of the high-
confidence hits from the RNAi screen, we assessed the set of upregulated host genes 
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during VACV infection for enrichment of HSF1-responsive genes (using a specifically 
defined set of 61 genes that have at least a two-fold increase in expression and have 
HSF1 bound to their promoters in multiple cell lines following a 42uC heat shock) 
(Mendillo et al., 2012). Remarkably, there were 25 HSF1-regulated genes enriched at 
least two-fold at 6 hpi in our VACV dataset, which encompassed 41% of the HSF1-
regulated gene list (genes in red, selected genes labeled; Figure	5.3B). HSF1-regulated 
genes highly expressed during VACV infection include 83% of the HSPs regulated by 
HSF1. This included HSPA6, which is not upregulated in cancer cells addicted to HSF1, 
but is strongly upregulated during a bona fide heat shock response (Mendillo et al., 
2012). A number of HSF1-regulated HSP activators and cochaperones (AHSA1, BAG3, 
CHORDC1, STIP1) were also expressed. 
To determine whether the increase in HSF1-regulated gene transcription was 
observed during VACV infection in other next generation sequencing datasets, we 
analyzed the data described by (Yang et al., 2010). In that study, HeLa cells were 
infected with a high MOI of VACV and total polyadenylated RNA was collected at 0 and 
4 hpi (termed the Whole Transcriptome Analysis (WTA) dataset A). We analyzed the 
WTA-A dataset, and found 981 genes upregulated over two-fold at 4 hours post VACV 
infection (genes in black; Figure	5.3C), with an approximately 30% overlap with the 
genes upregulated at least two-fold in our dataset. Of the 61 HSF1-responsive genes we 
previously reported, 28 were upregulated (46%) in the Yang WTA-A dataset (genes in 
red with selected genes labeled; Figure	5.3C). This correlates well with our data at 6 hpi, 
with 19 of the 25 HSF1-regulated genes expressed in both datasets (Table S7). The 
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overlap has good representation of the HSP70/HSP110 superfamily and HSF1-regulated 
HSP cochaperones and activators. Together, these data indicate that HSF1-transcribed 
genes are upregulated during VACV infection. Previously published HSP data and a 
retrospective analysis of microarray experiments tracking host gene expression following 
poxvirus infection showed an association with the maintenance or upregulation of HSF1-
regulated genes (Brum, Lopez, Varela, Baker, & Moyer, 2003; Guerra et al., 2003, 2006; 
Kowalczyk, Guzik, Slezak, Dziedzic, & Rokita, 2005; Sedger et al., 1996). These 
findings establish that the HSF1-regulated gene expression program is a dominant host 
transcriptional event stimulated by VACV infection. 
5.4.3 Orthopoxvirus Replication Requires Cell Stress Responses 
The integrated analysis of both the pooled RNAi screen and the RNAseq host 
transcription data indicated that HSF1 was an important host factor. Therefore, we began 
to investigate the potential role of HSF1 in controlling orthopoxvirus infection. HSF1, the 
master transcriptional regulator of the heat shock response, controls the expression of 
most heat shock genes both under basal conditions and following proteotoxic cellular 
stress (Anckar & Sistonen, 2011; Mendillo et al., 2012; Morimoto, 1998; Page et al., 
2006; Pirkkala, Nykänen, & Sistonen, 2001; Santoro, 2000; Trinklein, Murray, Hartman, 
Botstein, & Myers, 2004). The heat shock protein family is comprised of a large number 
of heat shock proteins (HSPs) with a broad range of chaperone functions. They are often 
designated by their molecular weight: HSPB (small HSPs), DNAJ (HSP40), HSPD, 
HSPA (HSP70), HSPC (HSP90) and HSPH, with most families containing multiple 
isoforms (Daugaard, Rohde, & Jäättelä, 2007; Easton, Kaneko, & Subjeck, 2000; 
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Kampinga et al., 2009; Shaner & Morano, 2007; Vos, Hageman, Carra, & Kampinga, 
2008). Our RNAseq data supported the hypothesis that these genes were actively 
transcribed during VACV infection. Together with the RNAi data, our results suggested 
that HSF1 is critical for orthopoxvirus replication; thus, we investigated the role of HSF1 
during orthopoxvirus infection more rigorously. 
We used five shRNA lentiviral vectors to create five independent stable cell lines 
with depleted HSF1. The knockdown efficacy of the shRNAs targeting HSF1 varied, 
with 23–61% of HSF1 remaining after selection. A representative immunoblot is shown 
in Figure	5.4A; the percent of HSF1 remaining after shRNA knockdown was quantified 
using four distinct anti-HSF1 antibodies (Figure	5.4B). The stable knockdown cells were 
infected with a VACV expressing Venus under an early promoter and TagBFP under a 
late promoter (Figure	5.4C) (Ken Dower et al., 2011). Hairpins that reduced HSF1 levels 
inhibited VACV gene expression, significantly decreasing both early and late gene 
expression when compared to a control hairpin (p,0.002). To validate this finding, cell 
lines with HSF1 knocked down at least 50% were infected with VACV at MOI 0.01 to 
measure viral growth in the absence of HSF1. We observed a ,1 log10 decrease in viral 
titer (90% inhibition of viral growth) at 24 hpi in the knockdown cells compared to 
control shRNA cells (Figure	5.4D). These data strongly support the HSF1 target 
specificity of the phenotype, indicating shRNA knockdown of HSF1 is limiting viral 
gene expression and viral growth. 
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Figure 5.4 HSF1 knockdown inhibits VACV infection.  
Five independent shRNAs targeting HSF1 were used to knockdown protein expression in 
A549 cells. The levels of HSF1 remaining after selection were quantified by immunoblot 
with several antibodies. (A) Representative immunoblot (anti-HSF1 J7F9). (B) The 
		
105 
average % HSF1 (6 standard error) remaining, quantified by immunoblot, is shown for 4 
different anti-HSF1 antibodies (see Materials and Methods). (C) HSF1-knockdown cells 
infected with VACV-TrpV expressing Venus under an early promoter and TagBFP under 
a late promoter show a significant decrease in VACV infection, as measured by early and 
late gene expression. Three independent experiments were completed in triplicate; this is 
a representative plot showing relative fluorescent units (RFU) with standard error. (D) 
Plaque assay showing VACV titer reduced by ,1 log when HSF1 protein level is reduced 
over 50%. 
 
We further confirmed the importance of HSF1 for VACV replication by 
analyzing virus infection in knockout mouse embryonic fibroblasts (MEFs) lacking HSF1 
(Dai, Whitesell, Rogers, & Lindquist, 2007; McMillan, Xiao, Shao, Graves, & Benjamin, 
1998). Infecting at MOI 0.01 with VACV-TrpV expressing Venus under an early 
promoter, mCherry under an intermediate promoter, and TagBFP under a late promoter, 
we observed that early, intermediate and late viral gene expression was inhibited in HSF1 
null MEFs (Figure	5.5A). Images in Figure	5.5B show the expected cytopathic effects 
(CPE) induced by vaccinia virus infection in wild type Hsf1+/+ MEFs, but no CPE in the 
absence of HSF1 (Hsf12/2 MEFs). This effect was specific to HSF1, as knockout of 
HSF2 had equivalent levels of infection and corresponding CPE to WT counterparts (data 
not shown). 
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Figure 5.5 HSF1 null MEF cells support significantly less VACV infection.  
(A) HSF1 null MEF cells infected with VACV-TrpV show significantly less early 
(Venus), intermediate (mCherry) and late (TagBFP) gene expression compared to wild 
type MEFs. Three independent experiments were completed in triplicate; this is a 
representative plot showing normalized relative fluorescent units (RFU) with standard 
error. (B) Brightfield images show HSF1 null MEFs exhibit less cytopathic effects than 
wild type MEFs when infected with VACV at an MOI of 0.1 at 18 hpi. Mock infected 
HSF1 null and wild type MEFs are included for comparison. 
 
In both the Hsf12/2 MEFs and the shRNA-knockdown cells, the depletion of 
HSF1 reduces VACV early, intermediate and late gene expression. This indicates that 
HSF1 is necessary for the entire VACV lifecycle, which is unexpected since 
orthopoxviruses package most of the viral factors necessary for early gene expression 
within the virion. Orthopoxviruses may need HSF1 directly or may activate its 
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transcriptional activity to enhance production of an HSF1-regulated target that is 
necessary for infection. 
5.4.4 Orthopoxvirus Infection Activates HSF1 
Our results demonstrating a role for HSF1 in vaccinia replication suggested that 
HSF1 was being activated following infection. In unstressed cells, HSF1 has been shown 
to exist as an inactive monomer in the cytoplasm, often in complexes with chaperone 
proteins. HSF1 undergoes an extensive set of posttranslational modifications, including 
phosphorylation, acetylation and sumoylation (Anckar & Sistonen, 2011). Upon 
activation, HSF1 is hyperphosphorylated and translocates to the nucleus to promote 
transcription of target genes (Guettouche, Boellmann, Lane, & Voellmy, 2005; 
Holmberg, Tran, Eriksson, & Sistonen, 2002; Jolly, Usson, & Morimoto, 1999; Santoro, 
2000). We investigated whether HSF1 was activated during VACV infection in a manner 
similar to its activation by heat shock. When cells were exposed to elevated temperatures 
(42uC), an increase in the phosphorylated form of HSF1 is observed (Figure	5.6A, lane 
1), when compared to the basal level of phosphorylated HSF1 in cells grown at 37uC 
(lane 2). Basal levels of HSF1 phosphorylation are seen in VACV-infected cells at 30 
minutes post infection (lane 3) suggesting that there is no immediate change in HSF1 
activation during virus entry. However, at later times in infection, levels of 
phosphorylated HSF1 strongly increased, similar to that seen following heat-shock 
(Figure	5.6A and Figure	5.6B). This demonstrated that VACV infection results in HSF1 
phosphorylation, an established marker of HSF1 activation (Holmberg et al., 2002). 
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Figure 5.6 HSF1 is activated during VACV infection.  
(A) Immunoblot showing HSF1 is phosphorylated on S326 following heat shock (42uC; 
lane 1). Basal levels of HSF1 phosphorylation are seen in mock and VACV infected cells 
30 minutes post infection (lanes 2 and 3). Basal levels of phosphorylation are seen in 
mock-infected cells at 24 hpi (lane 4), while HSF1 phosphorylation increases during 
VACV infection by 24 hpi (lane 5). The actin loading control is shown for all samples. 
(B) VACV induces HSF1 phosphorylation to similar levels as heat shock. Graph shows 
densitometry quantification of the phosphorylated HSF1 present in each sample 
normalized to the actin loading control with heat shock phosphorylation levels set at 
100%. (C) Immunofluorescence images in HFF-1 cells of HSF1 phosphorylation on S326 
(red, white arrows) show protein localization in mock cells (low levels, cytoplasm), heat 
shocked cells (increased phosphorylation, nucleus) or VACV-infected cells 5 hours post 
infection with MOI 1 (increased phosphorylation, nucleus). DAPI staining (blue) 
identifies nuclei. (D–G) A549 cells with HSF1 knocked down by five independent 
shRNA lentiviral vectors or a control vector were infected with VACV at MOI 0.1 for 18 
hours. (D) Cell lysates were immunoblotted for host proteins. Total HSF1, 
phosphorylated on S326 (activated) HSF1 and HSP27 are shown. The cells transduced 
with HSF1 shRNA express lower levels of HSF1 and HSP27 and show reduced 
phosphorylation of HSF1 upon VACV infection. (E) Graph shows densitometry 
quantification of the bands in (D). (F) Cell lysates were immunoblotted for VACV-
expressed proteins. Shown are I3L, an early protein, and a late protein recognized by a 
polyclonal antibody that recognizes late viral proteins. When HSF1 levels are reduced, 
there are lower levels of VACV proteins expressed. (G) Graph shows densitometry 
quantification of the bands in (F). 
 
To determine if phosphorylated HSF1 is relocating to the nucleus upon infection, 
we undertook immunofluorescence analysis of HSF1. In cells grown at 37uC, the HSF1 
antibody recognizing phosphorylation at S326 showed HSF1 located in the cytoplasm of 
primary human foreskin fibroblast (HFF-1) cells and A549 cells (white arrows, Figure	5.6C). During heat shock, phosphorylated HSF1 signal increases as HSF1 localizes to the 
nucleus (Figure	5.6C). Similarly, during VACV infection, phosphorylated HSF1 
translocated to the nucleus, indicating that VACV is activating HSF1 in a manner similar 
to heat shock. A different HSF1 antibody, recognizing pS303, shows a distinct staining 
pattern, with HSF1 in the nucleus in cells grown at 37uC and the development of nuclear 
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stress granules as evidenced by bright foci in the nucleus, upon heat shock or VACV 
infection. These data demonstrate that phosphorylated HSF1 is in the nucleus during 
VACV infection, with staining patterns similar to heat shock, consistent with activation 
of this transcription factor. 
In A549 cells with HSF1 depleted by shRNA knockdown, lower levels of total 
HSF1 correspond to a decrease in phosphorylated HSF1 during VACV infection (Figure	5.6D, quantitated in Figure	5.6E). The decrease in HSF1 activation following VACV 
infection corresponded with a decrease in expression of HSF1-transcribed genes, 
including HSP27 (Figure	5.6D and Figure	5.6E). The lack of HSF1 activation and 
downstream effectors led to a decrease in VACV gene expression as measured by 
fluorophores expressed from VACV promoters (Figure	5.4C), as well as expression of 
native VACV proteins measured by immunoblot. Here, the early viral protein I3 and a 
late protein recognized by a polyclonal antibody raised to virions, which are composed of 
predominantly late viral proteins, both show a decrease in protein levels when HSF1 is 
knocked down (Figure	5.6F, quantitated in Figure	5.6G). We see an inhibition of both 
early and late gene expression, with more inhibition of late gene expression than early 
gene expression. These data indicate that HSF1 activation, and perhaps transcription of 
downstream HSPs, is necessary for viral protein expression during VACV infection. 
5.4.5 HSF1 Inhibitors Block Orthopoxvirus Infection 
When HSF1 is depleted from the cell, the cellular milieu may be altered such that 
it is non-permissive for orthopoxvirus infection, or alternatively the virus may directly 
require active HSF1 transcription during infection. To differentiate between these 
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options, we pharmacologically inhibited HSF1 activity coincident with virus infection, 
for acute inhibition of HSF1 activity. We treated cells with several reported HSF1 
inhibitors, including triptolide (Westerheide, Kawahara, Orton, & Morimoto, 2006), 
KNK437 (Ohnishi, Takahashi, Yokota, & Ohnishi, 2004; Voyer & Heikkila, 2008; 
Yokota, Kitahara, & Nagata, 2000), quercetin (Elia, Amici, Rossi, & Santoro, 1996; 
Hosokawa et al., 1992; Nagai, Nakai, & Nagata, 1995), and KRIBB11 (Yoon et al., 
2011). The first three compounds do not bind HSF1 directly and likely influence HSF1 
activity indirectly, along with the activity of other cellular systems (Santagata et al., 
2013), while KRIBB11 has been reported to bind HSF1 directly (Yoon et al., 2011). One 
hour after drug treatment, the cells were infected with VACV expressing Venus from an 
early promoter and mCherry from a late promoter (VACV-LREV). All four drugs 
reduced viral gene expression from both early and late promoters in A549 cells (Figure	5.7A). More inhibition of late gene expression was observed compared to early gene 
expression; this may be due to the cascade transcription mechanism employed by 
poxviruses or HSF1 may be more important for late stages of infection than early. 
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Figure 5.7 Inhibitors that target HSF1 or HSF1-transcribed genes block VACV 
infection.  
(A) Inhibitors targeting HSF1 activity block VACV gene expression in A549 cells. Cells 
treated with 1 mM Triptolide, 50 mM Quercetin, 50 mM KNK437 or 50 mM KRIBB11 
were infected with VACV-LREV at MOI 1 for 16 hours. Cells were fixed and 
fluorescence read to measure early and late gene expression. Three independent 
experiments were completed in triplicate; this is a representative plot showing RFU 
normalized to DMSO control at 100% with standard error. (B) Inhibitors targeting HSF1 
activity block VACV infection in A549 and HeLa cells. Cells were treated with 
compounds at same concentrations as (A), and infected with VACV for 24 hours. Virus 
was collected and titered by plaque assay. HSF1 inhibitors block viral titers by 2–3 logs. 
(C) Inhibitors targeting HSF1-transcribed HSPs block VACV gene expression in A549 
cells. Cells treated with 1 mM STA9090, 50 mM KRIBB3, 50 mM PFTm and 100 mM 
Myricetin were infected with VACV-LREV at MOI 1 for 16 hours. Cells were fixed and 
fluorescence read to measure early and late gene expression. Three independent 
experiments were completed in triplicate; this is a representative plot showing RFU 
normalized to DMSO control at 100% with standard error. 
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All four HSF1-inhibitory drugs also blocked virus replication as measured by viral 
titer. The compounds inhibited viral growth by 2 to 3 log10 in both A549 and HeLa cells 
(Figure	5.7B). Although the inhibitors each have off target effects, the drugs all function 
to block HSF1 with different mechanisms, strengthening the conclusion that active HSF1 
transcription is necessary for orthopoxvirus replication, and that inhibition of HSF1 has 
antiviral effects. 
We also tested pharmacologic inhibitors of some of the heat shock proteins 
transcriptionally controlled by HSF1 and expressed during VACV infection, including 
HSP90, HSP70 and HSP27. PFTm interacts with HSP70 and prevents its activity (Leu, 
Pimkina, Frank, Murphy, & George, 2009), KRIBB3 prevents the phosphorylation of 
HSP27 (Shin et al., 2005, 2008), Ganetespib (STA-9090) binds to the ATP-binding 
domain in the N-terminus of HSP90 (Lin et al., 2008; Y. Wang, Trepel, Neckers, & 
Giaccone, 2010), while myricetin may block the interaction between members of the 
HSP40 and HSP70 families (L. Chang et al., 2011). Acute inhibition of heat shock 
protein activity significantly decreased VACV-LREV infection as determined by 
fluorophore expression from early and late gene promoters (Figure	5.7C). Similar to the 
HSF1-inhibitory drugs, late gene expression was more inhibited than early gene 
expression. Together, these data suggest that not only is HSF1 important for VACV 
infection, but that several major HSF1-regulated targets are important as well. 
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5.4.6 Monkeypox Requires HSF1 for Infection 
We next evaluated whether HSF1 could be a potential therapeutic target for other 
orthopoxviruses, in particular monkeypox, which currently leads to outbreaks in the 
human population (Rimoin et al., 2010). Knocking down HSF1 protein levels over 50% 
in A549 cells using four different shRNA sequences (Figure	5.4B) significantly inhibited 
MPXV early and late gene expression at 48 hpi. The expression of both eGFP, driven by 
an early MPXV promoter, and dsTomato Red, driven by a late MPXV promoter 
(Johnston et al., 2012), were significantly decreased when HSF1 levels were decreased 
(p,0.01; Figure	5.8A). 
 
Figure 5.8 HSF1 is also a critical host factor for monkeypox infection.  
(A) HSF1-knockdown cells infected with a modified MPXV expressing GFP under an 
early promoter and dsTomato Red under a late promoter show a decrease in MPXV 
infection, as measured by early and late gene expression normalized to MPXV infection 
in cells with no protein depletion. (B) The level of HSF1 protein remaining in the cell 
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following knockdown (x-axis) correlates with the inhibition of MPXV late gene 
expression during infection (y-axis). 
 
 These data strongly correlate with the efficacy of HSF1 knockdown for each 
shRNA, showing a clear relationship between the level of HSF1 present in the cell 
(Figure	5.4A and Figure	5.4B) and the ability of MPXV to express dsTomato Red from 
a late gene promoter (Figure	5.8B). For example, when HSF1 is knocked down with 48% 
protein remaining, MPXV late gene expression is 44.4%, while HSF1 knockdown with 
only 24% remaining results in 14.5% MPXV late gene expression. These data position 
HSF1 as a conserved host requirement of orthopoxvirus replication and as a potential 
pan-orthopoxvirus target for future therapeutic development. 
 
5.5 Discussion 
Here we identify HSF1, the master regulator of the host transcriptional response 
to proteotoxic cellular stress, as a critical host factor for orthopoxvirus infection. 
Identifying HSF1 as important resulted from the combined use of two unbiased 
experimental approaches: RNASeq and pooled shRNA screening. Pooled shRNA 
libraries have not yet been widely used to identify host factors important for virus 
replication, but may be a useful tool for probing the virus-host interaction on a genomic 
scale. While pooled screening is subject to the same false hit rates and cell toxicity issues 
as comparable arrayed format screens, our results show that both screening approaches 
identify components of similar cellular pathways. 
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Of our high-confidence hits, half (HSF1, JAG1, TNPO3, SKI) have a nuclear 
function or signal to transcription factors, which is interesting for a cytoplasmic virus. 
We also have a strong correlation with recently published host factors necessary for 
orthopoxvirus infection. Sivan et al recently described the importance of nuclear pore 
proteins in viral morphogenesis; we identified the nuclear import protein TNPO3 in our 
screen. JAG1, a Notch signaling molecule, is regulated by the Wnt pathway. The Wnt 
pathway was recently published to be important for Myxoma leporipoxvirus infection 
(Teferi, Dodd, Maranchuk, Favis, & Evans, 2013). We also identified ITGB1BP1, or 
ICAP1, which specifically binds to the cytoplasmic domain of beta1 integrin. Beta1 
integrin was recently shown to interact with VACV on the cell surface and signal through 
PI3K/Akt to facilitate VACV entry (Izmailyan et al., 2012). 
Previously published RNAi screens for necessary host factors during poxvirus 
infection of mammalian cells all also identified members of the heat shock response 
pathway, however the candidate genes were not validated or further developed in those 
publications (Mercer et al., 2012; Sivan et al., 2013; Teferi et al., 2013). Our screen was 
the only one to identify the master regulator of the pathway, HSF1, as important. The 
reason that our screen identified HSF1 and other screens did not is not immediately 
apparent, but it is notable that all of the screens enforce the idea that HSPs are important 
for viral replication. 
The activation of HSF1 helps unify a mechanism for how poxviruses control the 
expression of many host proteins that they utilize. Earlier reports established that several 
heat shock proteins associate with VACV proteins during infection. HSP90 interacts with 
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VACV core protein 4a (A10L), and colocalizes with the viral factory during specific 
stages of the virus lifecycle (Hung, Chung, & Chang, 2002). Evidence suggests several 
viral proteins are bound by HSP70/72 (Jindal & Young, 1992). HSP27 (HSPB1) binds to 
three VACV proteins in protein-interaction studies: a truncated TNF-a receptor-like 
protein (VACV-WR002), C2L kelch-like protein (VACV-WR026) and I4L 
ribonucleoside-diphosphate reductase large subunit (VACV-WR073) (Van Vliet et al., 
2009). Upregulation of HSF1 transcription provides a mechanism for how VACV and 
other poxviruses ensure sufficient levels of multiple chaperones through the activation of 
a single host protein. 
While other studies have shown that poxviruses can activate host transcription 
processes (Mazzon et al., 2013), our study suggests that the activation of HSF1 aids 
orthopoxvirus replication on multiple levels. In addition to the involvement of HSPs as 
mentioned in the previous paragraph, HSC70, HSP72 and HSP90 have been shown to be 
packaged within virions (Chung et al., 2006; Manes et al., 2008; Resch, Hixson, Moore, 
Lipton, & Moss, 2007), suggesting an importance for chaperones in early stages of virus 
infection. The continuous usage of host cell chaperones at multiple (if not all) stages of 
the virus lifecycle shows that poxviruses use the heat shock response to extend their 
genome, activating HSF1 to transcribe essential factors that are encoded by the host. 
A prediction of this genome extension hypothesis would be that some members of 
the family Poxviridae will have evolved to include one or more HSF1-stimulated genes in 
their own genome, reducing their dependence on host-production of HSPs. Consistent 
with this, genus Mulluscipoxvirus (Molluscum contagiosum; accession number 
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AAC55141) and genus Crocodylipoxvirus (Nile crocodilepox virus; accession number 
YP_784220) encode proteins with homology to the DNAJ/HSP40 chaperone family. 
Interestingly, other large, cytoplasmically replicating DNA viruses encode HSPs in their 
genome. This is most striking in the case of mimiviruses, which express HSP70 
(MIMI_L254), HSP40/DNAJ (MIMI_R269, MIMI_gp0838) and DNAK (MIMI_L393) 
homologs, suggesting the requirement for large amounts of these HSPs during viral 
replication is consistent across cytoplasmic large DNA viruses (Legendre, Santini, Rico, 
Abergel, & Claverie, 2011; Raoult et al., 2004). 
How orthopoxviruses activate HSF1 is an interesting question for future study. In 
unstressed cells, HSF1 is in an inactive form in the cytoplasm, bound to several proteins 
including HSP90 and HSP70. There are several proposed mechanisms of activation of 
HSF1, including the idea that recruitment of HSP90 and/or HSP70 away from HSF1 in 
the cytoplasm allows the free HSF1 to become post-translationally modified and 
translocate to the nucleus to begin transcribing genes (Guettouche et al., 2005; Holmberg 
et al., 2002; Jolly et al., 1999; Santoro, 2000). HSF1 may be activated during VACV 
infection when cytosolic HSP90 is recruited to the viral factory, as has been previously 
shown (Hung et al., 2002). Poxviruses also encode kinases, which may act to directly 
phosphorylate and activate HSF1 during VACV infection. Finally, orthopoxviruses may 
indirectly activate HSF1 by stimulating the MAPK signaling pathway (Andrade et al., 
2004), which in turn strongly drives HSF1 activity (Dai et al., 2012). Understanding these 
mechanisms may provide insight into how an invading virion can manipulate the levels 
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of a selective set of host proteins while also deploying proteins that reduce the general 
level of host mRNAs. 
Together, these data unify previously disparate observations regarding 
individually identified heat shock proteins and poxvirus infection. Earlier studies had 
illustrated the importance of individual members of the heat-shock response, but had not 
established whether poxviruses co-opted existing proteins or whether a heat-shock 
response was activated. Both our shRNA screening data and transcriptomic analysis 
implicate HSF1 activation as an important aspect of the orthopoxvirus lifecycle. This has 
implications not only for understanding viral evolution but also offers potential antiviral 
targets. Furthermore, our studies underscore that the HSF1 pathway is a viable target for 
broad-spectrum antiviral development, as it is a core cellular process used by multiple 
viruses, including HIV and EBV (Rawat & Mitra, 2011; F. W. Wang et al., 2011). A 
more complete understanding of how perturbing cellular homeostasis benefits viral 
replication will be important for illuminating the biology of virus-host interactions and 
for recognizing new therapeutic possibilities. 
 
. 
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CHAPTER 6  
VIRAL BIODIVERSITY OF RODENTS IN FRENCH GUIANA  
6.1 Preamble 
In this chapter, I describe the viral metagenomics work that I carried out in the 
Pasteur Institute in French Guiana, as part of a four-month internship funded by the 
International Division of the Pasteur Institute. My project was a pilot study to 
characterize the viral diversity of rodents living in three different regions of French 
Guiana. I was in charge of analyzing the sequencing data, comparing the performance of 
different alignment methodologies, and collaborating with experimental biologists to 
define best practice guidelines for future studies. 
6.2 Introduction 
Recent technological advances in the field of metagenomics have made it possible 
to collect a biological sample from a specific environment and characterize its viral 
composition. Unlike traditional metagenomic approaches—where ribosomal DNA is 
used to monitor bacterial diversity—, there is no universally conserved gene present 
across all viral families. Traditionally, viruses have been detected by looking for 
cytopathic effects on infected cell cultures, or by using neutralization tests (Niklasson, 
Jahrling, & Peters, 1984; Russell & Nisalak, 1967). Viral pathogens that are not 
culturable under these conditions, or for which no quality antiserum exists, have eluded 
identification efforts. Molecular methods like PCR have been used over the past few 
decades to overcome some of these hurdles, but these approaches require knowing the 
sequences of the target viruses before they can be identified. This limitation is starting to 
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disappear with the development of shotgun metagenomic sequencing (Bibby, 2013), 
which uses high-throughput sequencing to blindly characterize the viral diversity in an 
environmental sample. 
The process starts by isolating viral particles, extracting genetic material from 
them, reverse transcribing RNA into cDNA, and fragmenting these nucleic acids until 
they become small enough to be sequenced. Sequencing generates millions of 
corresponding reads, which represent the genetic sequences of different organisms 
present in the sample: the host and all the bacteria, viruses, and eukaryotic parasites that 
inhabit it. The reads can be optionally assembled into longer contiguous sequences 
known as contigs, which are then compared with the genomes of previously sequenced 
species using a combination of local and global alignment. A given viral species is 
assumed to be present in a sample if enough associated reads or assembled contigs align 
with high similarity to its reference genome.  
Here, I describe two approaches, raw read-based and contig-based, to characterize 
the viral diversity of serum and spleen samples from mice (Mus musculus) captured in 
three different regions of French Guiana, corresponding to habitats with different levels 
of human perturbation: urban, semiurban and unperturbed. The main findings are that 
host contamination is a critical issue for assessing viral diversity, and that both raw read-
based and contig-based approaches are useful methods and provide complementary 
information. 
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6.3 Methods 
6.3.1 Sample preparation 
A serum and a spleen sample were taken from three different mice, one for each 
geographic location: Cayenne (urban), Macouria (semiurban), and Cavaliers Trois 
Palétuviers (unperturbed). ApoH-coated magnetic beads (ApoH Technologies, 
Villeneuve Saint Georges, France) were used to isolate intact viral particles. Beads were 
equilibrated in PBS and 10 ul of a 50% bead mixture in PBS was used for each 1.5 ml of 
serum or spleen homogenate. After a two-hour incubation period at 37ºC, beads were 
recovered using MagneSphere Technology Magnetic Separation Stands (Promega). After 
being washed three times with PBS, the beads were resuspended in RNA extraction 
buffer (Sigma-Aldrich) and RNA was extracted according to the manufacturer’s protocol. 
The RNA was reverse-transcribed with the Transplex whole transcriptome amplification 
(WTA) kit (Sigma-Aldrich), using a quasi-random primer, according to the 
manufacurer’s protocol. Sequencing was carried out on an Illumina Miseq using 250 bp 
paired-end reads. 
6.3.2 Metagenomic Analysis 
Trimmomatic (Bolger et al., 2014) was used to discard low-quality reads, trim low-
quality bases and remove adapter sequences. The reference alignment and the de novo 
assembly methods detailed below used this subset of processed reads.  
Reference alignment using sequencing reads 
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The blastn (Camacho et al., 2009) tool was used to align processed sequencing 
reads to the mouse genome. Reads that had alignments with an E-value < 10-3 were 
considered to originate from the host and were discarded from further analysis. The 
resulting set of reads was aligned using blastn, blastx and usearch (Edgar, 2010) against 
the viral sequences contained in the nucleotide and amino acid non-redundant databases 
from NCBI. Each high similarity match (E-value < 10-9) was assigned a corresponding 
species, kingdom and taxonomic family by combining multiple files from the NCBI 
taxonomy database.  
 
De novo assembly with and without digital normalization 
Processed reads were assembled into contigs using SPAdes (Bankevich et al., 
2012) with k-mer size k=41. This assembler performs a previous error-correction step 
using BayesHammer (Nikolenko, Korobeynikov, & Alekseyev, 2013). Additionally, 
processed reads were digitally normalized using khmer (Brown, Howe, Zhang, Pyrkosz, 
& Brom, 2012), a single-pass algorithm that normalizes coverage in shotgun sequencing 
datasets, which decreases sampling variation, and removes redundant data and the 
majority of sequencing errors. 
 
6.4 Results 
6.4.1 The majority of metagenomic sequences originate from the host 
 The six sequencing samples that were analyzed contained an average of 3.5 
million paired reads. After using blastn to align the reads against the mouse genome, 
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between 28% to 68% of the reads showed high-score alignments with mouse genes, 
which likely indicates that these reads were the result of sequencing host nucleic acids, 
and provides evidence that the viral purification process was not virus-specific. Figure	6.1 shows the proportion of reads based on their host or non-host origin for each of the 
serum and blood samples in each type of environment. 
 
 
Figure 6.1: Sequencing reads of mouse origin for serum and spleen samples.  
Red bars indicate the percentage of processed sequencing reads aligning to the Mus 
musculus genome with a high score. Blue bars indicate the percentage of reads that don’t 
align to the mouse genome or that do so with a low score. 
 
6.4.2 Detecting viral sequences by directly aligning reads to a reference genome 
After discarding reads that likely originated from the host, I assessed the diversity 
of viruses in the samples by directly aligning the remaining reads against a database of 
viral sequences using the usearch aligner. This resulted in multiple high-score 
alignments, but only five viral genomes accumulated more than 1000 aligned reads in at 
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least one of the samples (see Table	6.1): Torque teno felis virus (TTV), Lymphocytic 
choriomeningitis mammarenavirus (LCMV), Human Herpesvirus 6A (HHV-6A), Glypta 
fumiferanae ichnovirus (GfIV) and Choristoneura occidentalis granulovirus (ChocGV). 
 
Virus 
Semiurban 
Serum 
Semiurban 
Spleen 
Urban 
Serum 
Urban 
Spleen 
Unperturbed 
Serum 
Unperturbed 
Spleen 
TTV 0 0 6157 174 0 0 
LCMV 0 0 1020 26 0 3 
HHV-6A 59 180 71 1374 477 98 
GfIV 142 533 186 3534 1262 254 
ChocGV 4326 6225 124 432 1750 13342 
 
Table 6.1 Number of reads aligning to viruses in each sample. 
TTV is a single-stranded DNA virus from the family Anelloviridae. LCMV is a 
single-stranded RNA virus from the Arenaviridae family. Both viruses seem to be 
abundant only in mice captured in the urban environment, especially in the serum, and 
not in either of the other two environments. Figure	6.2 shows the number of reads that 
align to the genomes of these two viruses in each environment and tissue. 
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Figure 6.2: Read distribution of TTV and LCMV.  
The y-axis shows the number of reads that resulted in a high-score alignment against the 
Torque teno felis virus genome (left) or the Lymphocytic choriomeningitis 
mammarenavirus (right). The x-axis indicates the environment and the tissue associated 
with each sample. 
 
HHV-6A is a double-stranded DNA virus from the Herpesviridae family. GfIV is 
also a double-stranded DNA virus, but from the Polydnaviridae family. They both appear 
to be at least marginally present across most samples and environments. For serum, these 
viruses seem to be more abundant in samples from the unperturbed environment; while 
for spleen, they are more abundant in samples from the urban environment. Figure	6.3 
shows the number of reads that align to the genomes of these two viruses in each 
environment and tissue. 
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Figure 6.3: Read distribution of HHV-6A and GfIV.  
The y-axis shows the number of reads that resulted in a high-score alignment against the 
Human herpesvirus 6A genome (left) or the Glypta fumiferanae ichnovirus (right). The x-
axis indicates the environment and the tissue associated with each sample. 
 
 ChocGV is a double-stranded DNA virus from the Baculoviridae family. It 
appears to be present in unperturbed and semiurban areas, and seems to replicate more 
easily in the spleen than in serum. Figure	6.4 shows the number of reads that align to this 
genome in each environment and tissue. 
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Figure 6.4: Read distribution of ChocGV.  
The y-axis shows the number of reads that resulted in a high-score alignment against the 
Choristoneura occidentalis granulovirus genome. The x-axis indicates the environment 
and the tissue associated with each sample. 
 
6.4.3 De novo assembly and digital normalization  
 Previously, I aligned individual reads against a reference genome to determine the 
viral diversity of a sample. An alternative method is de novo assembly, which combines 
reads into longer contiguous sequences (contigs) and aligns them against the viral 
genome database. Some of the advantages of this approach include a reduction in the 
number of sequences to be compared (lowering computing time), more reliable and less 
ambiguous alignments. Many assemblers are currently being used to process 
metagenomic sequences (Nagarajan & Pop, 2013). In this chapter I have chosen to 
compare Velvet (Zerbino & Birney, 2008), one of the most widely adopted de novo 
assemblers, with SPAdes, a relative newcomer in the metagenomic field. In addition to 
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the previously described raw dataset, I generated a digitally normalized read subset using 
khmer. As can be seen in Figure	6.5A, the digitally normalized dataset contains 70-77% 
fewer sequencing reads than the raw dataset. This provides evidence that digital 
normalization is able to provide optimal performance with a drastically reduced dataset at 
lower computational cost. 
 Using Velvet and SPAdes to generate assemblies using the raw and the digitally 
normalized datasets resulted in strikingly different results. Figure	6.5B shows several 
metrics that evaluate the performance of each assembler in each dataset. The first 
observation is that assemblies produced with SPAdes have a larger number of contigs, 
and of greater average and maximum size than those produced using Velvet. The second 
observation is that even though there are 70% fewer reads in the digitally normalized 
dataset, the resulting assemblies have almost identical metrics to those generated using 
the raw dataset. 
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Figure 6.5: De novo assembly metrics.  
(A) Number of reads generated from two different serum samples (semiurban and urban). 
The dark red bars represent the number of reads generated by sequencing (the raw 
dataset). The pink bars represent the number of reads that were considered non-redundant 
(the digitally normalized dataset). (B) Assembly metrics for the serum samples. The 
green bars correspond to the assemblies generated using SPAdes and the orange bars to 
those generated using Velvet. Boxes in the left correspond to the raw dataset, while those 
in the right correspond to the digitally normalized dataset. 
 
Number of contigs (No DN) Number of contigs (DN)
Size of contigs (No DN) Size of contigs (No DN)
Max. Size Contig (No DN) Max. Size Contig (DN)
0
2000
4000
0
2000
4000
0e+00
1e+06
2e+06
3e+06
4e+06
0e+00
1e+06
2e+06
3e+06
4e+06
0
20000
40000
60000
0
20000
40000
60000
Urb
an_
Se
rum
Se
miu
rba
n_S
eru
m
Urb
an_
Se
rum
Se
miu
rba
n_S
eru
m
SPAdes
Velvet
0e+00
1e+06
2e+06
3e+06
4e+06
Se
miu
rba
n_S
eru
m
Urb
an_
Se
rum
Nu
m
be
r o
f r
ea
ds
No Digital Normalization
Digital Normalization
A B
		
131 
6.4.4 Digital normalization can lead to more efficient assemblies 
 After seeing that the contigs generated by SPAdes were more numerous and 
longer on average than those generated by Velvet, I wanted to confirm the performance 
for an individual genome. Using BLASTX to align each of the four assemblies (SPAdes-
DN, Spades-NoDN, Velvet-DN and Velvet-NoDN) from each sample against the NCBI 
viral database resulted in several high-score alignments, the longest of which came from 
the Urban-Serum sample, and matched the Lymphocytic choriomeningitis 
mammarenavirus. Figure	6.6 shows the size of the reference genome of the virus, along 
with the corresponding sizes of the longest contigs that aligned each segment in the four 
assemblies. The SPAdes-digitally normalized assembly contained the largest contigs (L 
segment: 6302 out of 6680 bp, S segment: 3324 out of 3376 bp), the contigs in the non-
digitally normalized were 6% smaller, while the ones generated using Velvet were 96-
97% smaller. 
 
Figure 6.6: Contigs that aligned against the Lymphocytic choriomeningitis 
mammarenavirus genome in the Urban-Serum sample.  
The x-axis shows the lengths (in base pairs) of the longest contig that aligned to the 
reference LCMV genome (L segment in the left, S segment in the right) in each of the 
four assemblies (Spades/Velvet and Normalized/Not normalized). 
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6.5 Discussion 
 The initial goal of the study was to identify pathogens present in mice that were 
living in regions of French Guiana that have experienced varying amounts of human 
perturbation (urban, semiurban and unperturbed). Unfortunately, multiple factors 
severely limited this goal. The number of samples and replicates from each region was 
not high enough to make any statistically robust predictions about region-specific viral 
biodiversity. Additionally, the experimental protocol that was used to prepare the samples 
for sequencing did not isolate viral particles with high efficiency, which resulted in the 
overwhelming majority of sequencing reads being generated from host RNA transcripts, 
with only a small percentage of sequences having a viral origin.  
 With the limited amount of data available, I was able to apply two different 
alignment strategies to obtain additional information about the most abundant viral 
sequences in the samples. Using reference-guided alignment tools, I identified the 
abundance patterns of five different viruses that had at least 1000 aligned reads in one of 
the samples. TTV and LCMV seemed to be most abundant in urban settings, while 
ChocGV was present in semiurban and unperturbed environments. The fact that multiple 
reads aligned to these genomes doesn’t mean that their corresponding viruses are in fact 
present in the host, but rather that one of the viruses present in the sample shares its 
genomic sequence with a known, previously-sequenced virus. The actual host species-
specific virus might not be identifiable until enough viral reads have accumulated to 
assemble the entire genome at high coverage. 
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Additionally, I applied de novo assembly methods to assemble reads into 
contiguous sequences, and assessed the effects of applying digital normalization to 
significantly reduce the number of reads needed to generate a high-quality assembly. 
Thanks to this technique, a reduction of approximately 70% in the number of reads used 
in the assembly generation step led to similar quality metrics than using all of the 
available reads. The advantage of using this approach is that it speeds up computation, 
lowers costs, and in some cases, increases performance. This is a direct consequence of 
the read-evaluation process of digital normalization, which discards reads that likely to 
contain low-frequency sequencing errors and results in higher-quality assemblies. In fact, 
the reason why the SPAdes assembler outperforms Velvet is likely to be the additional 
Bayesian error-correcting step that SPAdes incorporates in its pipeline (BayesHammer). 
This highlights the dependence between genome assembly and a low-error sequencing 
platform. 
Viral metagenomics is a promising new field that can be a powerful technique to 
answer important scientific questions related to biodiversity, epidemics, and species 
discovery. Future studies would benefit from ensuring that host-contamination is 
minimized and that the experimental design is appropriate for the scientific goals of the 
project. 
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